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Summary 
The genus Legionella consists of environmental bacteria which are the causative agents of 
the severe pneumonia Legionnaires’ disease. L. longbeachae and L. pneumophila are able 
to replicate intracellularly in human alveolar macrophages and aquatic or soil amoebae. In 
order to replicate within host cells the bacteria establish a compartment derived from the 
endoplasmatic reticulum (ER) which is called “Legionella-containing vacuole” (LCV). A 
bacterial intracellular multiplication/defective in organelle transport (Icm/Dot) type IV 
secretion system (T4SS) is essential for the formation of this LCV. The Icm/Dot T4SS 
enables translocation of effector proteins into the host cell. More than 100 effector proteins 
are presumably translocated during an L. longbeachae infection whereas around 300 
translocated effector proteins are known for L. pneumophila. During maturation the LCV 
communicates with vesicles from the endocytic vesicle trafficking pathway, avoids fusion 
with lysosomes and instead fuses with the ER. Phosphoinositides (PI) such as 
phosphatitdylinositol-4-phosphate (PtdIns(4)P) are enriched on the LCV which mediate 
the binding of Icm/Dot translocated effector proteins like SidCLpn (substrate of Icm/Dot 
transporter) as well as its paralogous protein SdcALpn.   
The 73 kDa effector SidM but not the 106 kDa SidCLpn was found in a previous 
phosphoinositide pulldown assay with L. pneumophila lysate to be the major PtdIns(4)P 
binding protein. Using L. longbeachae lysate we showed binding of the 111 kDa SidCLlo to 
PtdIns(4)P in a phosphoinositide pulldown. This result was confirmed by protein-lipid 
overlay assays using “PIP-strips”. In further analysis the P4C (PtdIns(4)P-binding of SidC) 
domain was identified as a 19 kDa domain of SidCLlo located in the amino acid region 609 
to 782. This P4C domain was located in the same region as the 20 kDa SidCLpn_P4C domain 
of L. pneumophila. Both P4C domains can be used as LCV markers. This was shown with 
GST-tagged proteins binding to LCVs in a cell homogenate. The two P4C domains show a 
sequence identity of only 45% and the full-length protein of 40%. Circular dichroism 
measurements revealed that the secondary structure of the two proteins is similar. 
Moreover, isothermal titration calorimetric measurements indicated a 3.4 higher affinity of 
SidCLlo towards PtdIns(4)P compared with SidCLpn. 
In RAW 264.7 macrophages infected with L. longbeachae we showed that endogenous 
SidCLlo as well as heterologously produced SidCLpn is translocated to the LCV in an 
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Icm/Dot-dependent manner. The deletion of the sidCLlo gene led to a reduced recruitment 
of calnexin to the LCV in infected Dictyostelium discoideum. This effect was 
complemented by adding plasmid-encoded SidCLlo, SidCLpn or SdcALpn. The same 
recruitment defect for a L. pneumophila strain lacking the sidCLpn and sdcALpn genes was 
complemented by the production of SidCLlo and SidCLpn as published before. Therefore, 
these effectors play a role for pathogen-host interactions by promoting the recruitment of 
ER to the LCV. L. longbeachae or L. pneumophila wild-type strains outcompeted their 
sidC deletion mutant in a competition assay in Acanthamoeba castellanii. However neither 
of the deletion mutants were impaired in their growth in single strain replication 
experiments. In summary despite of the small sequence identity and the higher binding 
affinity to PtdIns(4)P of SidCLlo compared to SidCLpn both effector proteins seem to have 
similar functions during an infection of Legionella. 
For the characterization of L. longbeachae-containing vacuoles through proteomic 
analysis, LCVs had to be isolated from infected D. discoideum or RAW 264.7 
macrophages. Endogenous SidCLlo or heterologously produced SidCLpn were used as LCV 
markers for the isolation. Pathogen vacuoles harbouring L. longbeachae were isolated by 
immuno-affinity purification using antibodies specifically recognizing SidCLlo or SidCLpn. 
Future investigations aim at optimizing the LCV purification protocol for L. longbeachae 
to determine the proteome composition of the L. longbeachae-containing vacuole. 
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Zusammenfassung 
Die Gattung Legionella besteht aus opportunistischen Pathogenen, die Auslöser für die 
schwere Lungenentzündung Legionärskrankheit sind. Die Legionella-Spezies                              
L. longbeachae sowie L. pneumophila vermehren sich intrazellulär in humanen alveolaren 
Makrophagen sowie in aquatischen oder im Boden lebenden Amöben. Ein vom 
endoplasmatischen Retikulum (ER) abstammendes Kompartiment ist notwendig für die 
intrazelluläre Replikation. Diese Nische wird als „Legionella-containing vacuole“ (LCV) 
bezeichnet. Die Bildung der LCV benötigt ein „intracellular multiplication/defective in 
organelle transport“ (Icm/Dot) Typ IV Sekretionssystem (T4SS), das Effektorproteine in 
die Wirtszelle transportiert. Zurzeit sind über 100 vermutete Effektorproteine für                      
L. longbeachae und etwa 300 Effektorproteine für L. pneumophila beschrieben. Im Verlauf 
eines Reifungsprozesses kommuniziert die LCV mit endosomalen Vesikeln, verhindert 
eine Fusion mit den Lysosomen und fusioniert mit dem ER. Phosphoinositide wie das 
PtdIns(4)P wurden auf der LCV gefunden. Diese dienen als Bindestellen für die durch das 
Icm/Dot translozierten Effektorproteine wie das SidCLpn und sein paraloges Protein 
SdcALpn.  
In einer früheren Studie wurde in einem Phosphoinositid-Pulldown Experiment das              
73 kDa Effektorprotein SidM aber nicht das 106 kDa Protein SidCLpn als Bindepartner von 
PtdIns(4)P nachgewiesen. Wir konnten in einem Phosphoinositid-Pulldown Experiment 
mit L. longbeachae Lysat zeigen, dass das 111 kDa homologe Protein von SidCLpn SidCLlo 
der Bindepartner von L. longbeachae für PtdIns(4)P ist. Ein 19 kDa großes SidCLlo-
Fragment im Bereich der Aminosäuren 609 bis 782 konnte identifiziert werden, das für die 
Bindung von SidCLlo an PtdIns(4)P notwendig ist. Interessanterweise liegt die früher 
beschriebene 20 kDa große P4C Domäne von SidCLpn in der gleichen Region. Durch 
Inkubation von GST-gekoppelten SidCLlo_P4C-Proteinen mit L. pneumophila 
Zellhomogenat konnten wir zeigen, dass SidCLlo_P4C die Vakuole von L. pneumophila 
homogen dekoriert. Daher kann SidCLlo_P4C genauso wie das SidCLpn_P4C als LCV Marker 
benutzt werden. Die P4C Domänen besitzen eine Sequenzhomologie von 45% und SidCLlo 
und SidCLpn zeigen eine Sequenzhomologie von 40%. Mittels zirkularer Dichroismus 
Messung konnte gezeigt werden, dass die beiden Proteine ähnliche Sekundärstrukturen 
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besitzen. Mittels isothermer Titrationskalorimetrie konnten wir zeigen, dass SidCLlo eine 
3.4-fach höhere Bindeaffinität zu PtdIns(4)P besitzt als SidCLpn. 
In infizierten RAW 264.7 Makrophagen konnte wir zeigen, dass L. longbeachae nicht 
nur sein eigenes endogen produzierten SidCLlo sondern auch ein heterolog exprimiertes 
SidCLpn in einer Icm/Dot abhängigen Art und Weise auf die LCV transloziert. Frühere 
Studien zeigten, dass in einer sidC-sdcALpn Deletionsmutante die ER Rekrutierung zu der 
LCV in infizierten D. discoideum Zellen beeinträchtigt ist. Wir konnten zeigen, dass die 
heterologe Produktion von SidCLlo diesen Rekrutierungsfehler komplementieren kann, 
ebenso wie Plasmid-kodiertes SidCLpn oder SdcALpn. Die Deletion vom Gen sidCLlo in                  
L. longbeachae führt ebenfalls zu einer verminderten Rekrutierung von ER-Markern zur 
LCV in infizierten D. discoideum. Dieser Effekt konnte durch eine Produktion von SidCLlo, 
SidCLpn und SdcALpn komplementiert werden. Die SidC Deletionsstämme von                           
L. longbeachae oder L. pneumophila replizierten in Acanthamoeba castellanii wie die 
entsprechenden Wildtyp-Stämme, aber in direkter Konkurrenz wurden die 
Deletionsmutanten von den Wildtyp-Stämmen verdrängt. Insgesamt scheinen trotz der 
geringen Sequenzidentität und der höheren Bindeaffinität von SidCLlo im Vergleich zu 
SidCLpn zu PtdIns(4)P beide Effektorproteine ähnliche Funktionen im Infektionsweg von 
Legionella wahr zu nehmen. 
Für die Charakterisierung von L. longbeachae-enthaltenden Vakuolen in einer 
Proteomanalyse müssen LCVs aus D. discoideum oder RAW 264.7 Makrophagen isoliert 
werden. Endogenes SidCLlo oder heterolog produziertes SidCLpn wurden als Vakuolen-
Marker für die Isolation von L. longbeachae-enthaltenen Vakuolen verwendet.                            
L. longbeachae-enthaltene Vakuolen wurden in einer Immunaffinitätsaufreinigung mit 
Hilfe spezifischer Antikörper gegen SidCLlo oder SidCLpn isoliert. Weitere Studien zielen 
auf die Verbesserung der Vakuolen-Isolation von L. longbeachae, um das Proteom dieser 
LCV zu charakterisieren. 
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1. General introduction 
1.1 Legionella spp. 
Legionella spp. are Gram-negative, obligate aerobe bacteria which live in a broad range of 
natural or man-made aquatic systems [4] or in potting soil [5, 6]. Two major Legionella 
species are L. longbeachae and L. pneumophila which both cause the severe pneumonia 
Legionnaires´ disease through inhalation of aerosols [7, 8]. The first and largest outbreak 
in the US history was in 1976 where American Legion members were infected by                  
L. pneumophila [5]. After this outbreak the genus was termed “Legionella” [5].                        
L. longbeachae serogroup 1 (Sg 1) was isolated for the first time from a patient with 
pneumonia in Long Beach, California, USA in 1981 [9]. In the same year the serogroup 2 
of L. longbeachae was discovered [10].  
 
1.2 Clinical diagnostic and therapy of Legionnaires’ disease 
Legionellosis is divided into two clinical diseases, Legionnaires’ disease, a severe 
pneumonia, and Pontiac fever [5]. Pontiac fever is a flue-like illness which is self-limiting. 
Legionellosis is causing a broad range of symptoms like myalgia, dyspnea, non-productive 
cough, headache, fever, rigors, delirium and diarrhea [11]. However Legionellosis cases 
are known where a person had no symptoms at all [5, 12]. It is not possible to distinguish 
between Legionnaires’ disease and other forms of pneumonia based on the symptoms only 
[5]. Even chest radiographic pictures look identical [13]. Cases are reported where Pontiac 
fever and Legionnaires’ disease were occurring during the same outbreak of Legionellosis 
[14]. 
From more than 50 known Legionella species L. pneumophila is causing around 90% 
and L. longbeachae less than 5% of the Legionellosis cases worldwide. L. longbeachae is 
mainly found in Australia and New Zealand where it accounts for 30% of the Legionellosis 
cases whereas L. pneumophila accounts only for 46% [15]. The diagnosis is based on a 
screen for L. pneumophila and therefore biases the statistic [5]. 15 different serogroups for 
L. pneumophila [5] and two serogroups for L. longbeachae are known. However, the 
serogroup 1 of L. pneumophila and L. longbeachae is mainly found in human infections [8, 
15].  
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L. pneumophila was first cultured on Mueller-Hinton agar which was supplemented 
with haemoglobin and IsoVitaleX (a supplemental mixture consisting primarily of sugars 
and cysteine). Later IsoVitaleX and haemoglobin were replaced by L-cysteine 
hydrochloride and soluble ferric pyrophosphate respectively [16]. Last the medium was 
replaced by a charcoal yeast extract (CYE) agar [17]. Lung tissue, blood and respiratory 
secretions like sputum and stool can be used to isolate Legionella [5]. Legionella can be 
detected by microscopic examination through a direct fluorescent antibody (DFA) but the 
specificity and sensitivity of this method is not optimal [14, 18]. Also a species-specific 
antigen for L. pneumophila is available which detects the serogroups 1 - 8 [19] but a cross-
reaction with Bacillus cereus spores is possible [20]. The antigen used in an urine antigen 
detection assay is only detecting the serogroup 1 of L. pneumophila [5]. 
Erythromycin is the major drug used to cure Legionnaires’ disease [5]. Moreover, 
azithromycin and levofloxacin are licenced through the Food and Drug Administration to 
cure this disease [5]. 
 
1.3 The accidental transfer of Legionella to a human  
L. pneumophila is mainly found in biofilms in water systems like cooling towers [21-25], 
shower heads and in natural sources like rivers and lakes [5, 25]. In 1989 a direct link 
between L. longbeachae and potting soil was found [5, 6] but no cases are known in which 
a person was infected with L. longbeachae through inhalation of aerosols from a water 
system. A human-to-human transmission was not observed for Legionella [23].  
A recently performed genome analysis of L. longbeachae revealed its environmental 
habitats [26]. Several genes for enzymes were found which are associated with plants like 
cellobiohydrolases, ß-glucosidases, glucanases, pectin lyases, endo-1,4-xylanase and 
chitinases. These enzymes could be used for the degradation of cellulose to use it as a 
carbon source. Furthermore, a putative cyanophycin synthase and a putative 
cyanophycinase, which are normally present in cyanobacteria, were found in the genome 
of L. longbeachae. Cyanophycin can be used as a storage compound for carbon, energy 
and nitrogen. L. pneumophila, on the other hand, possesses only genes for one putative ß-
glucosidase, an endo-1,4-glucanase, endo-1,4-xylanase and chitinase. The genomic 
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analysis also indicated a putative capsule-like structure for L. longbeachae NSW150, 
which was validated by electron microscopy and is not present in L. pneumophila [26].  
 
1.4 The infection cycle of Legionella  
In 1980 a L. pneumophila infection of A. castellanii and human monocytes under lab 
conditions was first reported [22, 27]. Legionella spp. are also able to infect and replicate 
in protozoan hosts like D. discoideum [3, 28, 29] and human and murine macrophages [3, 
30-32]. L. longbeachae can also replicate in A. castellanii [26]. Contrary to                                    
L. pneumophila, L. longbeachae can also replicate in C57BL/6 mice [33]. The cytosolic 
flagellin of L. pneumophila, which triggers the activation of Naip5-dependent caspase-1 
followed by a proinflammatory cell death through pyroptosis, seems to be the reason of 
this failure [34-38]. L. longbeachae does not trigger capase-1 activation in C57BL/6 mice 
macrophages and does not possess flagellar biosynthesis genes [26].  
L. pneumophila undergoes a biphasic life cycle in which it switches from a 
transmissive, virulent to a replicative, non-virulent phase [26]. In the post-exponential 
growth phase of a liquid over night culture L. pneumophila is virulent [30, 39].                           
L. pneumophila is using the flagella to reach host cells and is attaching through self-
produced adhesins to the cell surface [24]. The uptake is an Icm/Dot-dependent [40, 41] 
process which can take place as “coiling phagocytosis” [41-43] or macropinocytosis [40, 
44] (Figure 1.1). Non-motile L. longbeachae does not posses such a pronounced biphasic 
life cycle, but a chemotactic system was found in a genome analysis which is missing for 
L. pneumophila [26]. No invasion strategies are known for L. longbeachae. Amoebae are a 
suitable model to study the intracellular life cycle of Legionella since the creation of a 
LCV and the intracellular replication in protozoa and mammalian phagocytes are similar. 
After entering the cell the bacteria is remodelling the phagosome and a LCV is formed. 
The L. pneumophila-containing vacuole acquires components from the mitochondria, fuses 
with vesicles from the ER and communicates with vesicles form the early and late 
endosomal vesicle trafficking pathway (e.g. EEA1 (early endosomal antigen 1)) [45, 46] 
whereas fusion with the lysosome is avoided [43, 45, 47-51] (Figure 1.1). During 
maturation the shape of a L. pneumophila-containing vacuole changes from a tight to a 
spacious vacuole. Only the bacterial poles stay attached to the LCV [52, 53]. 1150 host cell 
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proteins were found on the LCV purified from macrophages [1] and 566 host proteins for 
D. discoideum [54] in a recent proteomics analysis. Only few details are known for the 
host factor composition of the L. longbeachae-containing vacuole. Acquisition of the early 
endosomal marker EEA1 and the late endosomal marker LAMP-2 was observed in U937 
macrophages. Also co-localization with the rough endoplasmatic reticulum (rER) was 
reported. An acquisition of the lysosomal marker Cathepsin D and the lysosomal tracer 
Texas red Ovalbumin (TROV) was not observed for L. longbeachae wild-type but for the 
dotA deletion mutant [30].  
L. pneumophila is switching from the transmissive, virulent to the replicative, non-
virulent phase [26]. During this process the expression of almost half of the genome 
expression is altered upon infection of A. castellanii [55]. L. pneumophila produces over 
300 different effector proteins which are translocated by the Icm/Dot T4SS into the host 
cell [56-58]. These effector proteins play a role in vesicle trafficking pathways and 
communication with host cell compartments. A modulation of the host cell response is 
initiated [59]. L. longbeachae possesses over 110 putative effector proteins [58] and 
replicates intracellularly irrespective of the bacterial growth phase [30] in a vacuole which 
recruits vesicles from the endoplasmatic reticulum [26, 30].  
L. pneumophila upregulates genes during the replicative phase, which are predicted to 
be necessary for the transmission to a new host cell. This includes genes for invasion and 
virulence such as the Icm/Dot T4SS system. The bacteria are preparing themselves for the 
next infection [55]. At the end of the intracellular replication phase the LCV in infected 
amoebae or macrophages is disrupted, a process which is independent of a bacterial pore-
forming activity in macrophages and the bacteria are released in the cytosol of the cell [60, 
61] (Figure 1.1). The pore-forming activity of the bacteria allows the cytolysis of the host 
cell [61-64]. L. pneumophila can also escape from infected A. castellanii in expelled 
vesicles and can survive in this vesicles for months [65]. L. longbeachae seems to escape 
from the cell like L. pneumophila within 24 hours. However, a pore-forming activity is 
missing [30, 66]. 
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Figure 1.1. L. pneumophila replicates in phagocytes. The bacteria invade phagocytes in an Icm/Dot- 
dependent way. A phagosome is built which fuses with endosomes [45, 46], ER-derived vesicles [47, 51] but 
avoids to fuse with lysosomes [67, 68]. The bacteria are replicating in the LCV. After replication the bacteria 
destroy the LCV and the plasma membrane of the cell [61-64]. The figure is based on a scheme published in 
[69]. 
 
1.5 Type II and type IV secretion systems 
L. pneumophila and L. longbeachae both possess a large number of secretion systems. The 
two major secretion systems are called Lsp type II secretion system (T2SS) and the 
Icm/Dot type IVB secretion system (T4BSS). Both secretion systems are necessary for the 
infection [8, 70]. Also, three type IVA secretion systems are present in the genome of                   
L. longbeachae but the Lvh T4ASS of L. pneumophila was not found in the genome [26]. 
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1.5.1 The Lsp type II secretion system (T2SS) 
A functional Lsp type II secretion system was found in the genome of L. pneumophila and 
L. longbeachae [8, 26]. Between 25 and 60 type II secreted proteins are known for                       
L. pneumophila [71]. 45% of the type II secreted substrates of L. pneumophila were 
missing in the genome of L. longbeachae [26]. 
 
1.5.2 The Icm/Dot type IVB secretion system (T4BSS) 
Many Gram-negative bacteria like Legionella use the type IV secretion system (T4SS) to 
transfer DNA substrates and proteins to the recipient cell [72]. A T4SS type A (T4ASS) 
and B are known. The Icm/Dot T4SS of Legionella spp. is part of the T4BSS which is 
independent of the T4ASS [72]. The secretion system is necessary for the efficient 
formation of a LCV and for the translocation of effector proteins into the host cell [50]. 
The protein identities and organization of the genes is 47% to 92%  similar between             
L. longbeachae and L. pneumophila [8].  
The Icm/Dot T4BSS system of Legionella comprises 27 proteins. Five proteins were 
found to be located in the cytoplasm and 16 proteins are connected with the inner 
membrane of the LCV. Additionally four outer membrane proteins and one periplasmic 
protein were identified. The type 4B secretion system contains nearly twice as many 
proteins as the VirB/D4 type 4A system of Agrobacterium tumefaciens which consists 11 
VirB proteins and a putative ATPase, VirD4 [72]. 
L. pneumophila genes called icm or dot code for proteins which form a membrane 
spanning transport complex. This complex is necessary for substrate translocation [73] and 
for intracellular replication [74-78]. Similarly organized genes were found to code for 
proteins which are related to Icm/Dot components. These DNA elements were located in 
the IncI plasmid colI-P9 and R64 and were necessary for conjugation. It seems as if the 
Dot/Icm system was adapted from a plasmid-encoded conjugal transfer system [79].  
The Icm/Dot T4SS system translocates effector proteins at different time points into the 
host cell. SidCLpn is translocated in an Icm/Dot-dependent way and localizes to the LCV at 
early time points of the infection [3, 80, 81]. The effector proteins LepA and LepB, which 
are important for the evasion of the bacteria from D. discoideum, are probably produced 
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and translocated during the later phases of the infection cycle [73, 82]. Effector proteins 
like LidA seem to be expressed and translocated during all growth phases [83].  
 
1.6 Phosphoinositide-binding Legionella effector proteins 
Today over 110 putative effector proteins are known for L. longbeachae [58]. 300 effector 
proteins are characterized for L. pneumophila [56, 58] which is equal to 10% of the total 
amount of proteins known [8]. Some effector proteins might be functionally redundant. 
After deletion of a single gene only few deletions lead to an intracellular growth defect of 
L. pneumophila [84-86]. The diversity of the Icm/Dot effector proteins might reflect the 
potential to infect different host cells [86]. After translocation of the effector proteins into 
the host cell the proteins decorate the LCV or target organelles or host factors in the host 
cell [50]. L. longbeachae lacks around 66% of the Icm/Dot substrates of L. pneumophila 
but possesses 51 novel putative Icm/Dot substrates [26].  
The first Icm/Dot substrate identified through bioinformatics analysis was RalF 
(Recruitment of Arf to Legionella phagosome) [73]. RalF recruits a member of the small 
GTPase family named ARF (ADP ribosylation factor) to the LCV and catalyzes a GDP-
GTP nucleotide exchange [87]. It was shown for RalF and LidA (Lowered viability in the 
presence of dotA) that the C-terminus of these effector proteins is necessary for the 
translocation of the protein by the Icm/Dot T4SS [84, 88]. A current assumption is that the 
secretion signal in general does not posses distinct amino acids at specific positions. 
Instead it is expected that the physicochemical properties of the amino acids at the last 35 
amino acids of the C-terminus are important [58].  
Several of these effector proteins of L. pneumophila have been mechanistically 
characterized. The effector protein SidK inhibits the vacuolar H+-ATPase [89], the 
autophagy machinery is modified by an effector protein called RavZ [90] and the retromer 
complex [91] or phosphoinositide (PI) lipids are also targeted [50, 92]. 
Many intracellular bacteria target the PI metabolism in order to be able to survive and 
replicate within the host cell [69, 93, 94]. PI lipids play an important role in the vesicle 
trafficking and signal transduction of eukaryotes [95] but the amount of PIs in the cell is 
low. Only around 10% of the total cellular phospholipids are PIs [96]. PI lipids are 
derivatives of phosphatidylinositol (PtdIns) composed of a diacylglycerol (DAG) backbone 
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and one D-myo-inositol 1-phosphate head group. The head group is oriented to the cytosol 
and can be phosphorylated by PI-kinases and dephosphorylated by PI-phosphatases at the 
3’, 4’ or 5’ position [50]. PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,4)P2, PtdIns(3,5)P2 
and PtdIns(3,4,5)P3 can be formed [45, 96].  
The distribution and function of the different PIs in the cell varies. Specific PIs together 
with small GTPases are responsible for the transport between subcellular compartments 
[97]. PI-metabolizing enzymes interconvert theses lipids. PIs have specific localisations 
within the cell and thus serve as organelle markers. PtdIns(3)P is mainly found on 
phagosomes, multivesicular bodies (MVBs) as well as on early endosomes [95-97]. 
PtdIns(4)P has a broad distribution. It is found on the plasma membrane, on secretory 
vesicles, the Golgi apparatus and the ER [95, 97, 98]. In an immunofluorescence analysis 
the localisation of PtdIns(4)P on the LCV was shown by an anti-PtdIns(4)P antibody. 
PtdIns(3,5)P2 is found in the later steps of the endosomal pathway [95]. PtdIns(4,5)P2 is 
enriched at the plasma membrane and together with PtdIns(3,4,5)P3 is located at sites of 
phagocytosis [96]. Proteins interact with PIs through specific PI lipid-binding domains like 
the pleckstrin homology (PH) domain which is known to bind to PtdIns(4)P [96, 99], 
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 [100]. Therefore, a purified eukaryotic PHFAPP1 domain 
coupled to GST can be used as a probe for PtdIns(4)P [80]. A number of effector proteins 
are known which modify PI lipids. LpnE might be important for binding of inositol 
polyphosphate 5-phosphatase OCRL1 (oculocerebrorenal syndrome of Lowe 1) to the LCV 
[50, 101] and SidF is a known PtdIns(3)-phosphatase [102].  
Many T4SS effector proteins of L. pneumophila are characterized to bind to PtdIns(3)P 
or PtdIns(4)P on the LCV. PtdIns(4)P-binding effector proteins are for example SidCLpn, 
its homolog SdcALpn [80, 92, 94, 103] and the GEF (guanine nucleotide exchange 
factor)/AMPylase (adenosine mono-phosphorylase) SidM (also known as DrrA) [45, 56, 
81, 104]. LidA is an example for a PtdIns(3)P-binding effector protein [83, 94].                       
L. pneumophila is interacting with the host cell regulation of PIs to form a replication-
permissive niche. Finally, also Legionella spp. are avoiding the lysosomal or 
autophagosomal pathway through imitating the lipid composition of the host cell 
organelles. This strategy is called “identity theft” [97]. 
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1.6.1 SidC and SdcA 
1.6.1.1 SidCLpn and SdcALpn of L. pneumophila  
The 106 kDa protein SidCLpn (substrate of Icm/Dot transporter) and its paralog SdcALpn are 
known Icm/Dot-dependent effector proteins of L. pneumophila which bind through 
PtdIns(4)P homogenously to the cytoplasmic side of the LCV [80, 84, 101, 103] (Figure 
1.2). SidCLpn and SdcALpn have an identity of 72% [3].. Both effector proteins also bind 
with a much smaller affinity to PtdIns(3)P [103]. The results were confirmed for SidCLpn 
by protein lipid overlay assays [3, 80]. A 20 kDa PtdIns(4)P-binding domain, termed 
SidCLpn_P4C (PtdIns(4)P-binding of SidC), was found to be the binding region for 
PtdIns(4)P. This P4C domain binds with higher affinity to PtdIns(4)P than the full length 
SidCLpn [3, 81]. The P4C domain is unique for prokaryotes and does not show any 
homology to eukaryotic PI domains [103]. A glutamate cluster called E-block in the C-
Terminus is important for the efficient translocation of SidCLpn [105]. 
Until now little is known about how PtdIns(4)P accumulates on the LCV and effector 
proteins like SidCLpn can bind to it [101]. The amoeba PtdIns(4, 5)P2 5-phosphatase Dd5P4 
(Dictyostelium discoideum 5-phosphatase 4) as well at its human homologue OCRL1, 
which hydrolyses PtdIns(4,5)P2 to produce PtdIns(4)P [50, 106], are found on the LCV 
and could be responsible for the production of PtdIns(4)P [101]. In a D. discoideum Dd5P4 
mutant less SidCLpn was found on the LCV. It is known that more SidCLpn binds to the 
LCV in infected D. discoideum if phosphatidylinositol 3-kinase (PI3K) is depleted because 
PI3K converts PtdIns(4)P to PtdIns(3,4)P2 and PtdIns(3,4,5)P3 [80]. In a RNA interference 
assay in Drosophila melanogaster Kc167 phagocytes the depletion of PtdIns 4-kinase IIIß 
(PI4KIIIß), which produces PtdIns(4)P, lowered the amounts of SidCLpn on the LCV. A 
depletion of the isoenzyme PI4KIIIα or PI4KIIα did not affect the SidCLpn binding to the 
LCV [81].  
SidCLpn is competing with SidM for the PtdIns(4)P binding site on the LCV. In a 
phosphoinositide-pulldown assay with PI-coated agarose beads only SidM but not SidCLpn 
was found to bind to PtdIns(4)P. Even in the absence of SidM no SidCLpn was detected 
[81]. Proteolysis of SidC was ruled out and it was found that the affinity of SidM and 
SidCLpn towards PtdIns(4)P is nearly the same. A masking “in cis” by a domain of SidCLpn 
could be the reason for the lack of binding in agreement with the finding that the P4C 
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domain is binding with a higher affinity to PtdIns(4)P than the full length SidCLpn. 
Alternatively, a complexation of SidCLpn with other L. pneumophila proteins could prevent 
the binding of SidCLpn [81]. Putative chaperones like IcmS and IcmW could be interactors 
for SidCLpn [81, 107, 108]. It was shown in an immunofluorescence analysis that in the 
absence of SidM more SidCLpn is binding to the LCV [81]. 
SidCLpn localizes to tight and spacious LCVs [80]. The deletion of the genes sidCLpn and 
sdcALpn in L. pneumophila does not lead to a decreased intracellular replication of the 
bacteria in D. discoideum, A. castellanii or macrophages. However, a slower and less 
pronounced interaction with the ER and a failure of the LCVs to develop from tight to 
spacious LCVs were results of this deletion [80, 103, 106, 109]. Also, the establishment of 
a replication-permissive LCV was delayed [109]. The deletion is causing a reduction of the 
ER markers HDEL and calnexin to the LCV, up to 20% for calnexin. The calnexin 
recruitment defect was complemented by plasmid-encoded SidCLpn or SdcALpn but not by 
plasmid-encoded SidCLpn_P4C. The LCVs of D. discoideum or RAW 264.7 macrophages 
infected with a sidC-sdcALpn deletion mutant were harbouring endosomal but not 
lysosomal markers [103]. The 70 kDa N-terminal domain of SidCLpn was binding ER and 
ER-derived vesicles like the full length SidC. Therefore SidCLpn and SdcALpn facilitate the 
acquisition of ER and ER-derived vesicles (Figure 1.2) through a N-terminal domain to the 
LCV [103]. It was postulated that the amino acids 225 to 323 are important for the 
interaction of SidCLpn with ER-derived vesicles over a host factor [109].  
The genes sidCLpn and sdcALpn are important for the early recruitment of LCV markers 
like ubiquitin and Arf1. The effect was only visible for Arf1 if both effector proteins were 
depleted indicating that the two effector proteins have redundant functions [109]. RalF 
recruits Arf1 to the LCV and RalF is a GEF for Arf1 [87, 110]. SidCLpn/SdcALpn did not 
affect the function of RalF, and therefore, their effect on the Arf1 recruitment seems to be 
indirect [109] (Figure 1.2).  
The absence of the effector proteins SidCLpn and SdcALpn did not result in a decreased 
recruitment of Rab1 to a LCV [103], but the deletion mutant caused a loss of the 
monoubiquitination of Rab1A (Figure 1.2). SidCLpn and SdcALpn had again a redundant 
function and the amino acids 222 to 315 were necessary for the ubiquitination. In liquid 
chromatography-mass spectrometry (LCMS) analysis the ubiquitin was found at lysine 
187. A temporary ubiquitination in the early steps of the infection was shown. Recently, a 
1. General introduction 
 
11 
 
structural analysis of the N-terminal fragment of SidC (amino acids 1 to 608) was 
published. The length of SidCLpn (around 220 Å) is comparable with other tethering 
proteins. No structural homolog was found [109]. 
Finally, in biochemical and biological assays the P4C domain can be used as a probe for 
PtdIns(4)P on the LCV [3, 103]. The full-length SidCLpn can be used in an immuno-affinity 
separation of LCVs from infected amoebae or macrophages [2, 54].  
 
 
Figure 1.2. The role of SidCLpn and SdcALpn on a L. pneumophila-containing vacuole. SidCLpn and 
SdcALpn are binding through PtdIns(4)P to the L. pneumophila-containing vacuole. Both effector proteins 
interact with the ER [80, 103, 106]. SidCLpn is competing with SidMLpn for PtdIns(4)P [81]. SidCLpn and 
SdcALpn promote the activation of Arf1, which is recruited to the LCV through RalF [87, 109, 110]. Rab1 is 
ubiquitinated by SidCLpn and SdcALpn [109].  
 
1.6.1.2 SidCLlo of L. longbeachae 
A 111 kDa homolog to SidCLpn was found in the genome of L. longbeachae and was 
named also SidC (SidCLlo). SidCLlo is a putative substrate of the Icm/Dot type IV secretion 
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system [26] (Figure 1.3). No sdcA gene was found in the genome of L. longbeachae [26] 
(Figure 1.3). 
 
 
Figure 1.3. The role of SidCLlo on a L. longbeachae-containing vacuole. It is not known if SidCLlo is 
translocated through the Icm/Dot T4SS into the cytosol of the host cell. It is possible that a translocated 
SidCLlo is binding through PtdIns(3)P, PtdIns(4)P or other PI lipids to the LCV. SidCLlo could also be located 
in the cytosol of the host cell. SidM and SdcA are missing in the genome of L. longbeachae [26]. 
 
1.6.2 SidM (alias DrrA) of L. pneumophila 
SidM is a 73 kDa Icm/Dot substrate of L. pneumophila which is translocated through a C-
terminal translocation signal. The effector protein binds through a 12 kDa PtdIns(4)P 
binding domain called P4M (PtdIns(4)P-binding of SidM/DrrA; amino acids 544 to 647) to 
PtdIns(4)P on the LCV during the early stage of infection [81, 111]. The binding affinity 
of the P4M domain for PtdIns(4)P is reduced compared to the full length SidM [81]. The 
structure of a SidM fragment including the P4M domain was analysed. A novel fold of the 
effector protein was found. This SidM fragment possesses a high affinity to PtdIns(4)P 
with a dissociation equilibrium constant (KD) of 30 nM [104]. The P4M binding domain 
has no similarity with the P4C domain of L. pneumophila or the PtdIns(4)P-binding PH 
domain of the adaptor protein phosphatidylinositol (4) phosphate adaptor protein 1 
(FAPP1) of eukaryotic cells. SidM is competing with SidCLpn for binding to PtdIns(4)P on 
the LCV. SidM also weakly binds to the phosphate in position 4 of PtdIns(3,4)P2, 
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PtdIns(4,5)P2 and PtdIns(3,4,5)P3 as well as to PtdIns(3)P [81]. The sidM gene is not 
found in the genome of L. longbeachae [26].  
SidM is a known GEF and GDF (GDI displacement factor) for the small GTPases Rab1, 
Rab8 and Rab14 of the Rho subfamily [54, 59, 81, 112, 113]. Two activation states of Rho 
GTPases are known. GTPases are inactive if they have bound a guanine nucleotide 
dissociation inhibitor (GDI) and GDP. In the active state the GDP is exchanged by a GTP 
through a GEF and the GDI is removed. In this state the GTPases interacts with 
downstream effector proteins such as adaptor proteins, lipid kinases and proteins. GTPases 
of the Rho subfamily play a role in regulation of the actin cytoskeleton and in signal 
transduction pathways of eukaryotes [114].  
SidM binds through its P4M domain [81] to PtdIns(4)P located on the LCV. SidM 
activates Rab1 through its GDF activity [111, 115, 116] and catalyses a GDP-GTP 
exchange [104, 111, 112, 115-118] through its GEF activity in the central part [119]. 
Finally, SidM is bound to Rab1-GTP [45] (Figure 1.4). Rab1 is necessary for the vesicle 
transport from the ER to the Golgi [81].  
The N-terminal part of SidM possesses also an “AMPylation” (adenosine mono-
phosphorylation) activity for the switch II region of Rab1. This switch II region of Rab1 is 
involved in the interaction with GEF, GDI and GAP [109, 119, 120]. The “AMPylation” is 
important for the retention of Rab1 on the LCV [116]. The Icm/Dot-dependent effector 
protein LidA was found to be an Icm/Dot substrate which decorates the LCV [83, 121]. 
LidA is binding to PtdIns(3)P and with lower affinity to PtdIns(4)P [81]. LidA is binding 
to GDI-free Rab1 and therefore facilitates the recruitment of early secretory vesicles to the 
LCV [112, 113, 115, 121]. Through the binding to Rab1 LidA supports the GEF activity of 
SidM [113]. LidA can interact with Rab1 modified by different covalent modifications like 
AMPylation and phosphocholination. It is also able to prohibit the dephosphocholination 
through the effector protein Lem3 or the de-AMPylation of Rab1 through the effector 
protein SidD [122]. Also, an interaction of LidA with small Rab GTPases like Rab6 and 
Rab8 was described (Figure 1.4). 
The effector protein SidD deampylates Rab1-GTP [123, 124]. LepB dephosphorylates 
the GTP of Rab1 and binds to the LCV and Rab1-GDP. Thus, Rab1 is inactivated [116]. 
Therefore LepB is the antagonist of SidM [111]. A GDI binds to Rab1-GDP, removes it 
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from the surface of the LCV and the cycle starts again with the activation of GDI bound 
Rab1-GDP through SidM [104, 111, 112, 115, 117, 118] (Figure 1.4). 
Rab1-GTP bound SidM can also be phosphocholinated by AnkX. This is not required 
for the retention of Rab1 to the LCV [116]. AnkX is inhibiting the formation of a Rab1-
GDP:GDI complex [125]. Lem3 dephosphorylcholinates Rab1, and consequently Rab1 is 
accessible for the effector protein LepB [126].  
 
 
Figure 1.4. Effector proteins compete with SidM for Rab1 on the L. pneumophila-containing vacuole. 
An Icm/Dot T4SS system is necessary for the translocation of effector proteins into the host cell. Some of the 
effector proteins bind through PI lipids (PtdIns(3)P and PtdIns(4)P) to the LCV. Theses effector proteins can 
modifiy the small GTPase Rab1 and possess different activities like a GEF and GDF activity (SidM), GAP 
activity (LepB), de-phosphocholinase (Lem3), phosphocholinase (AnkX) or deampylase (SidD). The figure 
is based on the scheme published in [45]. 
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1.7 Aims of the Ph.D. thesis 
At the onset of this thesis not a single L. longbeachae effector (among more than 100 
candidates) was biochemically characterized. Using PI lipids covalently coupled to agarose 
beads, we thought to identify PI-binding L. longbeachae proteins in an unbiased screen. 
Thus, we identified the L. pneumophila homologue of L. pneumophila SidC as a PI-
binding protein. The genome of L. longbeachae NSW150 was published in the first half of 
2010. A homolog of SidCLpn was identified and the protein corresponding to the gene 
llo3098 was termed SidCLlo [26]. Therefore, we characterized SidCLlo and compared it to 
SidCLpn using genetic, biochemical and cell-biological approaches. Since the available 
SidCLpn antibody did not recognize SidCLlo in a Western blot or in an immunofluorescence 
analysis, a SidCLlo antibody was produced.  
Another aim of the thesis was to isolate and purify intact LCVs harbouring                            
L. longbeachae. To this end, a protocol based on immuno-affinity purification, previously 
established for L. pneumophila, was used. The goal was to perform a proteomic analysis of 
the L. longbeachae-containing vacuole. LCV purifications were tried with infected                   
D. discoideum as well as with infected RAW 264.7 macrophages.  
Taken together, this thesis aimed at a better understanding of LCV formation and 
intracellular replication of L. longbeachae. 
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2. Materials and methods 
2.1 Materials 
2.1.1 Bacterial strains 
The bacterial strains listed in table 2.1 were used (Table 2.1). 
 
Table 2.1. Bacterial strains*. 
Strain Property Reference 
E. coli   
TOP10 --- Invitrogen 
BL21 (DE3) --- Novagen 
L. longbeachae   
NSW150 L. longbeachae Serogroup 1 [26] 
∆dotA 
IH02 
NSW150 dotA::KanR (∆dotA) 
NSW150 sidCLlo:Kan
R (∆sidCLlo) 
[26] 
[3] 
L. pneumophila   
JR23 L. pneumophila Philadelphia strain 1 [127] 
GS3011 JR32 icmT3011::KanR (∆icmT) [128] 
LELA3118 JR32 dotA3118::KanR (∆dotA) [127] 
CR001 JR32 sidC-sdcA:KanR (∆sidC-sdcALpn) [103] 
*Abbreviation: kanamycin (Kan) 
 
2.1.2 Eukaryotic cell lines 
The eukaryotic cell lines listed in table 2.2 were used (Table 2.2). 
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Table 2.2. Eukaryotic cell lines*. 
Cell line Property Reference 
Acanthamoeba 
castellanii 
--- ATCC 30234 
RAW 264.7 
macrophages 
--- ATCC TIB-71 
D. discoideum   
AX3/pCaln-GFP Pact15, calnexinA-RSSSKLK-GFP (S65T), 
G418 
[129] 
*Abbreviation: geneticin sulphate (G418) 
 
2.1.3 Plasmids 
The plasmids listed in table 2.3 were used (Table 2.3). 
 
Table 2.3. Plasmids*. 
Plasmid Property Reference 
pCetLI1 pZT-llo0105-cyaA-C (P7) [58] 
pCR02 pGEX4T-1, GST-sidCLpn (Ptac) [80] 
pCR34 pMMB207-C, M45-sidCLpn (Ptac) [80] 
pCR77 pMMB207-C, dsred (Ptac) [91] 
pCR80 pMMB207-C, dsred (Ptac), sidCLpn (Ptac) [91] 
pET28a(+) N-terminal His6-fusion, Kan
R (PT7) Novagen 
pGEX4T-1 N-terminal GST-fusion, AmpR (Ptac) Amersham 
pGEX-PH_FAPP1 pGEX4T-1, GST-PH_FAPP1 (Ptac) [130, 131] 
pHP056 pGEX4T-1, GST-sidCLpn_609-776 (Ptac) [103] 
pIH031 pMMB207-C-cyaA-sidCLlo (P7) unpublished 
pIH047 pMMB207-C-RBS-dsredexpress-RBS-sdcA 
(Ptac) 
[3] 
2. Materials and methods 
 
18 
 
pIH060 pGEX4T-1, SidCLpn_1-608-Llo_609-969 (Ptac) [3] 
pMH01 pGEX4T-1, sidCLlo_1-608-Lpn_609-917 (Ptac) [3] 
pMMB207-C-M45 pMMB207-C, ∆mobC, M45-(Gly)5, Cam
R 
(Ptac) 
[80] 
pSD01 pET28a(+); His6-sidCLlo (P7) [3] 
pSD02 pET28a(+); His6-sidCLlo (P7); deletion of 
BamHI and SalI in sidCLlo 
[3] 
pSD03 pGEX4T-1, GST-sidCLlo_609-782 (Ptac) [3] 
pSD04 pGEX4T-1, GST-sidCLlo_1-340 (Ptac) [3] 
pSD05 pGEX4T-1, GST-sidCLlo_341-608 (Ptac) [3] 
pSD06 pGEX4T-1, GST-sidCLlo_783-969 (Ptac) [3] 
pSD07 pGEX4T-1, GST-sidCLlo (Ptac) [3] 
pSD13 pMMB207-C, M45-sidCLlo (Ptac) [3] 
pSD14 pMMB207-C, dsred (Ptac), sidCLlo (Ptac) [3] 
pSH097 pMMB207-C-cyaA (Ptac) [91] 
pSH098 pMMB207-C-cyaA-sidC (Ptac) [91] 
pSW001 pMMB207-C, ∆lacIq, constitutive dsred (Ptac) [132] 
*Abbreviations: ampicillin (Amp); chloramphenicol (Cam); kanamycin (Kan) 
 
2.1.4 Oligonucleotides 
The oligonucleotides listed in table 2.4 were used (Table 2.4). 
 
Table 2.4. Oligonucleotides [3]. 
Oligo Sequence (5' - 3') 
*
 Comment 
oSD07 TTTTCATATGATGAGAGTCACTAAAATGCCT
AAAGAC 
5' flanking sequence of 
sidCLlo (fo) 
oSD08 TTTTTGCTAGCTTAAGTACGTGAATTAAAAGT
ACGTCC 
3' flanking sequence of 
sidCLlo (re) 
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oSD16 TTTTG GGATCC ATG AGA GTC ACT AAA ATG 
CCT AAA GAC 
5’ of sidCLlo 
oSD17 TTTTTGTCGACTCATCCAGTGATTTTTTCTAC
GTC 
3' of sidCLlo_1-340 (re) 
oSD18 TTTTGGGATCCGCTGCTGTTATTTCCTGGG 5' of sidCLlo_609-782 (fo) 
 
oSD19 
 
TTTTTGTCGACTCATTCATTGAAAAAGTTAAG
CGCTG 
 
3' of sidCLlo_609-782 (re) 
oSD22 GAAAATAATATCAAGGCATGGTCCACTGATC
TTGAAGCAATCG 
Quick Change of 
sidCLlo (SalI) (fo) 
oSD23 CGATTGCTTCAAGATCAGTGGACCATGCCTT
GATATTATTTTC 
Quick Change of 
sidCLlo (SalI) (re) 
oSD24 AAACGCGGATCCGATGAATCACAGCAAAAG
GAAGC 
5' of sidCLlo_341-608 (fo) 
oSD25 AAACGCGTCGACTCAATTTTCTCTATTCACGT
TTGCTGGAG 
3' of sidCLlo_341-608 (re) 
oSD26 AAACGCGGATCCTTGTCTTTACATGAGGTGC
TTAAAGTAGC 
5' of sidCLlo_783-970 (fo) 
oSD27 AAACGCGTCGACTTAAGTACGTGAATTAAAA
GTACGTCC 
3' of sidCLlo_783-970 (re) 
oSD28 GATGAGTTCTTTTTGATGGACCCCAATAGAA
AAGG 
Quick Change of 
sidCLlo (BamHI) (fo) 
oSD29 CCTTTTCTATTGGGGTCCATCAAAAAGAACT
CATC 
Quick Change of 
sidCLlo (BamHI) (re) 
*The restriction sites are underlined. 
 
2.1.5 Lab equipment 
The lab equipments listed in table 2.5 were used (Table 2.5). 
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Table 2.5. Lab equipments. 
Application Name of the lab equipment Supplier 
autoclave STERIMAQUET MAQUET 
Bunsen burner FIREBOY plus INTEGRA Biosciences 
cell culture centrifuge Megafuge 40R Thermo Scientific 
cell homogenizer --- Isobiotech  
centrifuge 3-30K Sigma  
centrifuge Centrifuge 5415R Eppendorf 
centrifuge Sorvall®RC-5B Du Pont  
colony counter Countermat Flash IUL  
confocal fluorescence 
microscope 
Leica Sp5 TCS  Leica 
culture microscope Primo Vert Zeiss  
diaphragm vacuum pump MZ 2C Vacuubbrand  
electrophoresis chamber Mini-Subcell GT/ 
Subcell GT/ 
Mini-Protean 3 
Bio-Rad 
electroporation device GenePulser XCellTM Bio-Rad  
FACS machine FACS CantoTM II BD Bioscience 
French Press SIM-AMINCO Spectronic  
gel imaging system ChemiDoc MP System Bio-Rad  
hot plate magnetic stirrer RCT basic IKA  
ice cube machine AF30 Scotsman  
incubation cabinet Orbital shaker, Forma Thermo Scientific 
incubator Heraeus BR6000/  
Heraeus Function Line 
Thermo Scientific  
incubator IPP400/ IPP500 Memmert 
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magnetic separator MACS multistand Miltenyi Biotec  
medical film processor FPM-100A  FUJIFILM 
mixer Vortex-Genie 2 IKA  
pH-meter Level 1 inoLab  
pipettes pipetman Gilson  
pipettor pipetus Hirschmann  
plate reader FLUO star OPTIMA BMG Labtech GmbH 
power supply PAC100 Bio-Rad  
precision balance BP61-S Sartorius  
precision balance PG2002-S Mettler-Toledo  
protein transfer device MAXI-Semi-Dry-Blotter Roth  
rocking platform  Duomax 1030 Heidolph  
spectrophotometer NanoDrop ND-1000  PeqLab  
spectrophotometer Libra S12 Biochrom 
thermocycler T3 Biometra  
thermomixer  Thermomixer Comfort Eppendorf  
ultracentrifuge OPTIMATM TL Beckham 
UV transilluminator --- Bachofer  
water bath Wasserbad 1005 GFL  
wheel for cups and falcons KABE Mischgerät BM 92 KABE Labortechnik 
 
2.1.6 Software and data bases 
The figures were created with “Microsoft Excel” (Microsoft) and “Corel Draw” (Corel). 
The amino acid alignment was made by “ClustalOmega” alignment (EMBL-EBI 
homepage). 
 
2. Materials and methods 
 
22 
 
2.2 Methods 
2.2.1 Legionella spp. 
2.2.1.1 General growth conditions 
L. longbeachae and L. pneumophila were frozen in glycerol stocks (section 2.2.1.2). This 
stocks were used to inoculate charcoal yeast extract agar (CYE) plates (Table 2.6) [17]. 
The bacteria were grown at 37°C for 3 days and diluted in ACES yeast extract medium 
(AYE) (Table 2.7) [48] to an optical density at 600 nm (OD600) of 0.1. 2 x 10
9 bacteria ml-1 
correlate to an OD600 of 3.0. The overnight cultures were cultivated for 18 till 21 hours on 
a rotating wheel at 37°C until the culture reached the stationary growth phase. A brown 
colour of the bacterial solution indicated this growth phase. 10 µg ml-1 (L. longbeachae) or 
5 µg ml-1 chloramphenicol (Cam) (L. pneumophila) were added to the overnight culture in 
which the bacteria harboured a plasmid with a Cam resistance. 0.5 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) (Roth) was added to the medium if a gene under the control 
of a Ptac-promotor was to be induced.  
 
Table 2.6. Charcoal yeast extract agar (CYE) [17]*. 
Component Per liter agar Supplier 
ACES 10 g AppliChem 
Bacto yeast extract 10 g BD Biosciences 
activated charcoal 2 g Fluka 
agar 15 g Serva 
L-cysteine 0.4 g in 10 ml dH2O Sigma 
FeN3O9 x 9H2O 0.25 g in 10 ml dH2O Sigma 
*The ACES and Bacto yeast extract were dissolved in dH2O and adjusted to a pH of 6.9.             
10 M KOH (Merck) was used for the adjustment. The solution was added to the activated 
charcoal and agar. A stir bar was added. The agar was autoclaved and cooled down to 
50°C. Filter sterilized (Filter Glass Microfiber Filter, WhatmanTM) L-cysteine solution was 
slowly added to the medium followed by the filter sterilized iron solution. An antibiotic 
was added if needed (5 µg ml-1 of chloramphenicol for L. pneumophila, 10 µg ml-1 of 
chloramphenicol for L. longbeachae, 50 µg ml-1 kanamycin). 
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Table 2.7. ACES yeast extract medium (AYE) [17]*. 
Component Per liter medium Supplier 
ACES 10 g AppliChem 
Bacto yeast extract 10 g BD Biosciences 
L-cysteine 0.4 g in 10 ml dH2O Sigma 
FeN3O9 x 9H2O 0.25 g in 10 ml dH2O Sigma 
*ACES and the Bacto yeast extract were dissolved in dH2O. The dissolved L-cysteine was 
slowly added to the medium followed by the iron solution. The pH was adjusted with 10 M 
KOH to 6.9. The medium was filtered six to eight times through a glass fiber filter 
followed by a filtration step with a filter with a smaller pore size (500 ml Rapid-Flow 
Bottle Top Filter, A. Hartenstein). The medium was stored at 4°C. 
 
2.2.1.2 Glycerol stock 
A single colony was used to inoculate 3 ml AYE in a test tube (section 2.2.1.1). The 
culture was cultured for 18 till 21 hours on a rotating wheel at 37°C until it reached the 
stationary phase. The culture was mixed with glycerol (Roth) to a final glycerol 
concentration of 25%. The mixture was frozen in liquid nitrogen in a cryovial (Thermo 
Scientific) and stored at -80°C.  
 
2.2.1.3. Production of electrocompetent Legionella spp. 
2.2.1.3.1 L. longbeachae 
L. longbeachae were streaked out from a glycerol stock densely on a CYE plate (section 
2.2.1.2). The bacteria lawn was harvest with an inoculating loop and resuspended in sterile 
ice cold dH2O. The suspension was diluted to an OD600 of 2.0. The bacterial mixture was 
washed two times with 10 ml ice cold sterile dH2O (3.350 x g, 10 minutes, 4°C) and one 
time with 10 ml ice cold sterile 10% glycerol. 250 µl of ice cold sterile 10% glycerol were 
used to resuspend the bacterial pellet. This bacterial suspension was used immediately for a 
transformation [133].   
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2.2.1.3.2 L. pneumophila 
L. pneumophila was grown in an overnight culture to pre-stationary phase (section 2.2.1.1). 
1 ml of the overnight culture was added to 30 ml AYE. The culture was grown at 37°C on 
a rotating wheel to an OD600 of 0.3 till 0.5 and cooled down. The bacteria were washed 
three times (5.000 x g, 5 minutes, 4°C) with 10 ml sterile, ice cold 10% glycerol. After the 
last washing step the bacterial pellet was resuspended in 160 µl sterile, ice cold 10% 
glycerol and aliquoted in portions of 25 µl. The aliquots were frozen in liquid nitrogen and 
stored at -80°C.  
 
2.2.1.4 Transformation of electrocompetent Legionella 
2.2.1.4.1 L. longbeachae 
50 µl of the electrocompetent bacteria (section 2.2.1.3.1) were mixed with three to five µg 
of DNA on ice and transferred in a precooled cuvette with a 2 mm electrode gap (Gene 
Pulser Cuvette, Bio-Rad). The cell suspension was electroporated in a GenePulser XCellTM 
Electroporation Systems (Bio-Rad) (2.4 kV, 200 Ω, 0.25 µF). 1 ml AYE medium was 
added to the cell suspension and the bacterial solution was transferred in a test tube. The 
culture was incubated for five hours at 37°C on a rotating wheel. The bacterial solution 
was plated onto CYE plates with the necessary antibiotics. Colonies appeared after four till 
five days [133]. 
 
2.2.1.4.2 L. pneumophila 
One aliquot of the electrocompetent bacteria (section 2.2.1.3.2) were mixed with 100 ng of 
DNA on ice. The bacteria/DNA mixture was transferred to a precooled cuvette with an       
2 mm electrode gap. The bacteria/DNA mixture was electroporated (2.5 kV, 200 Ω,                 
25 µF). The solution was mixed with 450 µl AYE medium and transferred to a test tube. 
The culture was incubated for five hours at 37°C on a rotating wheel. The bacterial 
solution was plated onto a CYE plate with an appropriate antibiotic. 
 
2. Materials and methods 
 
25 
 
2.2.2 Escherichia coli 
2.2.2.1 General growth conditions 
Escherichia coli was streaked out from a glycerol stock (section 2.2.2.2) with an 
inoculating loop on a Luria-Bertani (LB) agar plate (Invitrogen) and cultivated over night 
at 37°C. An overnight culture was inoculated with one E. coli colony. The culture was 
grown in LB broth base (Invitrogen) over night at 37°C on a shaker. Antibiotic was added 
to the LB agar plates and LB broth if necessary (Table 2.8). A gene under Ptac-control was 
induced by adding 0.5 mM IPTG to the LB broth. 
 
Table 2.8. Antibiotics. 
Component MW [g/mol] Final concentration Supplier 
ampicillin (Amp) 371.39 g mol.1 100 µg ml-1 Roth 
chloramphenicol (Cam) 323.13 g mol-1 30 µg ml-1 AppliChem 
kanamycin (Kan) 582.58 g mol-1 50 µg ml-1 Sigma 
 
2.2.2.2 Glycerol stock 
An E. coli overnight culture (section 2.2.2.1) was diluted with glycerol to a final 
concentration of 25%. The mixture was transferred into a cryovial tube, frozen in liquid 
nitrogen and stored at -80°C. 
 
2.2.2.3. Production of chemical competent E. coli 
A small overnight culture of E. coli was inoculated in LB broth medium and cultivated at 
37°C on a shaker (section 2.2.2.1). 100 ml of a fresh LB broth base culture was inoculated 
with 1 ml of the overnight culture. The culture was incubated until the OD600 reached 0.5. 
The following steps were performed on ice. The culture was transferred in a 50 ml test 
tube, cooled down for 15 minutes and washed once with 40 ml ice cold TFB1 (Table 2.9) 
(3.350 x g, 15 minutes, 4°C) and once with 4 ml ice cold TFB2 (Table 2.10). The bacterial 
solution was incubated for 15 minutes on ice. 50 µl aliquots were aliquoted, frozen in 
liquid nitrogen and stored at -80°C.  
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Table 2.9. TFB1*, **. 
Component Concentration Gram Supplier 
KAc 30 mM 1.41 g Roth 
KCl 100 mM 3.73 g Merck 
CaCl2 x 2H2O 10 mM 0.74 g Merck 
MnCl2 50 mM 3.15 g Fluka 
glycerol 15% 150 ml Roth 
*Distilled H2O was added to reach a final volume of one liter. 
**The pH of the solution was adjusted to 5.8 with 0.2 N acetic acid (Roth). The solution 
was filter sterilized and stored in aliquots of 40 ml at -20°C. 
 
Table 2.10. TFB2 *, **. 
Component Concentration Gram Supplier 
MOPS (3-(N-morpholino) 
propanesulfonic acid) 
10 mM 0.105 g Sigma 
CaCl2 x 2H2O 75 mM 0.552 g Merck 
KCl 10 mM 0.037 g Merck 
glycerol 15% 15 ml Roth 
*Distilled H2O was added to reach a final volume of 50 ml. 
**The pH of the solution was adjusted to 6.5 with KOH (Merck), filter sterilized and 
stored in aliquots of 4 ml at -20°C. 
 
2.2.2.4 Transformation of chemical competent E. coli 
The chemical competent bacteria were thawed on ice (section 2.2.2.3). 100 ng of DNA 
were added to the bacteria. The bacteria were incubated on ice for 30 minutes. A heat 
shock was performed at 42°C for one minute. The bacteria were cooled on ice for two 
minutes and transferred with 1 ml LB broth medium in a test tube. The culture was 
incubated at 37°C on a shaker for one hour. The culture was plated onto LB agar plates 
with the appropriate antibiotic. Colonies appeared after one day at 37°C. 
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2.2.3 Dictyostelium discoideum 
2.2.3.1 General growth conditions 
Dictyostelium discoideum strain Ax3 was cultivated axenically in HL-5 medium (Table 
2.11) at 23°C in a 75 cm2 flask (Tissue culture Flask 75, TPP Technic Product Plastics AG) 
[80, 134]. In case D. discoideum harboured a plasmid encoding geneticin sulphate (G418) 
resistance, 20 µg ml-1 G418 (Roth) was added to the medium.  
 
Table 2.11. HL5-medium [135]*, **. 
Component Gram Supplier 
D(+)-glucose-monohydrate 11 g Fluka 
BBLTMYeast Extract 5 g BD Biosciences 
bacteriological peptone 5 g BD Biosciences 
Na2HPO4  0.355 g Fluka 
KH2PO4  0.34 g Oxoid 
*Distilled H2O was added to reach a final volume of one liter.  
**The pH of the solution was adjusted to 6.5 with 1 M KOH or 1 M HCl (Roth). The 
medium was autoclaved and stored at 4°C. Geneticin sulphate was added to the medium 
(20 µg ml-1) if necessary. 
 
2.2.3.2 Storage of D. discoideum 
The axenically grown amoebae were cultivated in a 75 cm2 flask (section 2.2.3.1). The 
cells of one confluent flask were centrifuged (500 x g, 10 minutes, room temperature (RT)) 
and resuspended in 9 ml freezing medium (Table 2.12). 1 ml of the cell suspension was 
aliquoted into a cryovial. A freezing box (NalgeneTM Cryo 1°C Freezing Container, 
Nalgene) was filled with isopropanol and precooled at 4°C. The cryovials were transferred 
into the freezing box and frozen at -80°C over night. The cells were stored permanently in 
liquid nitrogen. 
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Table 2.12. Freezing medium. 
Component Percentage [%] Supplier 
HL-5 80% self made (2.2.3.1) 
FCS 10% Gibco 
DMSO 10% Merck 
 
2.2.3.3 Thawing of D. discoideum 
One frozen cryovial was thawed on ice (section 2.2.3.2). The cell solution was washed 
once (500 x g, 5 minutes, RT) with 10 ml HL-5 medium to remove the DMSO. The cells 
were resuspended in 10 ml HL-5 medium and transferred to a 75 cm2 flask. 
 
2.2.4 Acanthamoeba castellanii 
2.2.4.1 General growth conditions 
A. castellanii were cultivated in PYG medium (Table 2.13) at 23°C in a 75 cm2 flask. 
 
Table 2.13. PYG medium*, **. 
Component Concentration (stock, 
in dH2O) 
Gram or 
ml 
Supplier 
bacteriological peptone --- 20 g BD Biosciences 
Bacto Yeast extract --- 1 g BD Biosciences 
MgSO4 x 7H2O 0.4 M 10 ml Merck 
CaCl2 0.05 M 8 ml Merck 
sodium-citrate x 2H2O 1 M 3.4 ml Roth 
Fe(NH4)2(SO4)2 x 6H2O --- 20 mg Fluka 
Na2HPO4 x 7H2O 0.25 M 10 ml Fluka 
KH2PO4 0.25 M 10 ml Oxoid 
*Distilled H2O was added to reach a final volume of one liter.  
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**The pH of the solution was adjusted to 6.5 with HCl. 50 ml of a 2 M glucose dissolved 
in dH2O was added to the medium. The medium was filter sterilized twice with a pore size 
of 0.45 µm and once with a pore size of 0.2 µm. 
 
2.2.4.2 Storage of A. castellanii 
A. castellanii were grown in a 75 cm2 flask (section 2.2.4.1). The cells of one confluent 
flask were centrifuged (500 x g, 10 minutes, RT) and resuspended in 9 ml freezing medium 
(Table 2.14). 1 ml of the cell solution was transferred to a cryovial and stored in a freezing 
box overnight at -80°C. The cryovials were transferred into a liquid nitrogen tank 24 hours 
later. 
 
Table 2.14. Freezing medium. 
Component Percentage [%] Supplier 
PYG 80% self made (2.2.4.1) 
FCS 10% Gibco 
DMSO 10% Merck 
 
2.2.4.3 Thawing of A. castellanii 
One frozen cryovial (section 2.2.4.2) was thawed on ice. The cells were resuspended in                     
10 ml PYG medium to remove the DMSO from the medium. The cells were transferred 
with PYG medium in a 75 cm2 flask and cultivated at 23°C. 
 
2.2.5 RAW 264.7 macrophages 
2.2.5.1 General growth conditions 
RAW 264.7 macrophages were cultivated in RPMI 1640 medium (Gibco). 10% fetal calf 
serum (FCS; Gibco) and 2 mM L-glutamine (Gibco) were added to the medium. The cells 
were cultivated at 37°C with 5% CO2. 1% of a penicillin/streptomycin mixture (Omnilab) 
was added to the medium if needed. 
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2.2.5.2 Storage of RAW 264.7 macrophages 
RAW 264.7 macrophages were grown in RPMI 1640 medium supplemented with                       
L-glutamine and FCS (section 2.2.5.1). The cells of one confluent 75 cm2 flask were 
harvested using a cell scraper. The cells were sedimented (500 x g, 10 minutes, RT) and 
resuspended in 3 to 4 ml of a freezing medium (Table 2.15). 1 ml of the cell suspension 
was transferred to a cryovial, frozen over night in a freezing box at -80°C and stored 
permanently in a liquid nitrogen tank. 
 
Table 2.15. Freezing medium. 
Component Percentage [%] Supplier 
RPMI 1640 45% Gibco 
FCS 45% Gibco 
DMSO 10% Merck 
 
2.2.5.3 Thawing of RAW 264.7 macrophages 
Frozen RAW 264.7 macrophages were thawed on ice (section 2.1.5.2). The DMSO was 
removed by washing the cells once with 10 ml RPMI 1640 medium supplemented with              
L-glutamine and FCS (500 x g, 10 minutes, RT). The cells were transferred to a 75 cm2 
flask and cultivated at 37°C with 5% CO2.  
 
2.2.6 Cell counting 
10 µl of a cell suspension were applied to a “Neubauer counting chamber” 
(Glaswarenfabrik Karl Hecht). The cells were counted under the microscope. The total 
amount (N) of cells per ml solution was calculated with the formula: 
Ncounted cells/quadrant x 10
4 = Ncells ml
-1. 
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2.2.7 Cloning 
The vectors for cloning were bought from Novagen, Amersham or were available in the 
lab (section 2.1.3). The polymerase, restrictions enzymes, ligase and DNA Ladder were 
bought from BioLabs, Fermentas and Thermo Scientifics.  
1% agarose gels were poured with dissolved agarose (Biozym LE Agarose, Biozym) in 
1x TAE agarose running buffer (Table 2.16). Ethidium bromide (Sigma) was added. A 
DNA standard was used (1 kb DNA Ladder, BioLabs).  Plasmid purification and agarose 
gel purification was done using kits from Macherey-Nagel (NucleoSpin ® Plasmid, 
NucleoSpin ® Gel and PCR Clean-up). The plasmids were sequenced by GATC Biotech 
(Konstanz, Germany).  
The gene sequence of sidCLlo was amplified by PCR from the genome of                           
L. longbeachae with the oligonucleotides oSD07 and oSD08 and cut with NdeI and NheI. 
The gene was cloned in a pET28(a)+ vector (Novagen) cut with the same enzymes to 
create a N-terminal His6-fusion. The gene was under the control of a T7 promotor. The 
plasmid was called pSD01. This plasmid was used to insert silent mutations in order to 
remove the restrictions sites BamHI and SalI from the gene sidCLlo 
(QuickChange®Lightning Site-Directed Mutagenesis Kit, Agilent Technologies) (pSD02) 
(sections 2.1.3 and 2.1.4). 
The gene sidCLlo_609-782 was amplified by a PCR using pSD02 as a template and oSD18 
and oSD19 as the oligonucleotides (sections 2.1.3 and 2.1.4). The gene was cut with 
BamHI and SalI and ligated into a pGEX4T-1 (Amersham) vector cut with the same 
enzymes (pSD03) (section 2.1.3) to create a N-terminal GST-fusion. A Ptac promotor 
controlled the expression of the gene.  
The plasmids pSD04 (GST-sidCLlo_1-340, oligonucleotides oSD17 and oSD52), pSD05 
(GST-sidCLlo_341-608, oligonucleotides oSD24 and oSD25), pSD06 (GST-sidCLlo_783-969, 
oligonucleotides oSD26 and oSD27) and pSD07 (GST-sidCLlo, oligonucleotides oSD27 
and oSD52) were cloned by using the same protocol (sections 2.1.3 and 2.1.4). 
The gene sidCLlo was cut with BamHI and SalI from the plasmid pSD07 and ligated into 
a pMMB207-C-M45 vector [80] cut with the same enzymes (pSD13). The same procedure 
was used to ligate sidCLlo into a pCR77 vector [91] (pSD14) (section 2.1.3). 
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Table 2.16. 50x TAE buffer*. 
Component Gram Supplier 
TRIS 242 g MP Biomedical 
acetic acid [100%] 57.1 ml Roth 
ethylendiamintetraacetate 
(EDTA)  
100 ml Roth 
*Dissolved dH2O was used to fill up the buffer to one liter. 
 
2.2.8 Protein analysis 
2.2.8.1 Protein separation by sodium dodecyl sulphate polyacrylamide gel    
electrophoresis (SDS-PAGE) 
5x sodium dodecyl sulphate (SDS) sample buffer (Table 2.17) was added to the protein 
sample. The mixture was boiled for 5 minutes at 95°C. A 10% SDS-polyacrylamide gel 
(Table 2.18) was poured and fixed in an electrophoresis chamber (Mini-Protean ® 3, Bio-
Rad). The chamber was filled with 1x running buffer (Table 2.19). A protein marker (Page 
RulerTM Prestained Protein Ladder, Thermo Scientific) were used. 
 
Table 2.17. 5x SDS sample buffer*. 
Component Concentration Supplier 
TRIS (pH 6.8) 0.2 M MP Biomedical 
SDS 4.3 g Biomol 
bromphenolblue 1 µg Sigma 
glycerol 15 ml Roth 
dH2O 45 ml --- 
ß-mercaptoethanol 8.5 ml AppliChem 
*The SDS sample buffer was frozen in aliquots at -20°C. 
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Table 2.18. SDS gel. 
Component Concentration for 
the stacking gel 
Concentration for 
the running gel 
[10%] 
Supplier 
acrylamide/bis-solution 
[40%] 
2.5 ml 1.25 ml Serva 
dH2O 5 ml 6.15 ml --- 
0.5 M TRIS (pH 6.8) --- 2.5 ml MP Biomedical 
1.5 M TRIS (pH 8.8) 2.5 ml --- MP Biomedical 
20% SDS 50 µl 50 µl Biomol 
10% ammonium 
persulphate (APS) 
30 µl 30 µl Biomol 
N, N, N’, N’ 
tetramethylethylendiamin 
(TEMED) 
15 µl 15 µl Biomol 
 
Table 2.19. 10x running buffer*. 
Component Gram Supplier 
TRIS 30.25 g MP Biomedical 
glycine 144.5 g MP Biomedical 
SDS 10 g Biomol 
*The solution was filled up to one liter with dH2O. 
 
2.2.8.2 Coomassie staining of a SDS gel 
SDS-polyacrylamide gels were stained with a Coomassie staining solution (Table 2.20) to 
visualize proteins. 
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Table 2.20. Coomassie staining and destaining solutions*. 
Component Concentration for 
the Coomassie 
staining solution  
Concentration for 
the Coomassie 
destaining solution  
Supplier 
Coomassie® 
Brilliant Blue R250 
0.25% --- Fluka 
ethanol 40% 40% Roth 
acetic acid 10% 10% Roth 
*Distilled H2O was used to set the volume of the buffer to one liter. 
 
2.2.8.3 Silver staining of a SDS gel 
The SDS-polyacrylamide gel (section 2.2.8.1) was incubated in a fixation solution (one 
hour till overnight). The SDS gel was washed three times with 50% ethanol for 20 minutes 
at RT. Between the washing steps the SDS gel was bathed in dH2O for two to three 
minutes at RT. The SDS gel was pre-treated with 0.13g l-1 sodium thiosulfate (Merck) (in 
dH2O) for one minute at RT and washed three times with dH2O over 20 seconds at RT. 
The SDS gel was incubated over 20 to 30 minutes at RT in fresh made impregnating 
solution (Table 2.21). The gel was washed three times over 20 seconds (RT) in dH2O. The 
SDS gel was incubated in a developing solution (RT) (Table 2.22) until brown bands 
appeared. The SDS gel was washed with 50% methanol (Roth) followed by 50% ethanol 
for one to two minutes at RT. The gel was dried afterwards. 
 
Table 2.21. Impregnating solution*. 
Component Concentration  Supplier 
AgNO3 0.1 g Merck 
37% formaldehyde 37.5 µl Merck 
*The buffer was adjusted with distilled H2O to 50 ml. 
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Table 2.22. Developing solution*. 
Component Concentration  Supplier 
Na2CO3 30 g Merck 
sodium thiosulfate 1.25 mg Merck 
37% formaldehyde 0.25 ml Merck 
*Distilled H2O was used to set the volume of the buffer to 500 ml. 
 
2.2.8.4 Western blot analysis 
The SDS gel (section 2.2.8.1) was laid on a nitrocellulose membrane (A. Hartenstein), 
covered with chromatography paper (A. Hartenstein) from both sides and laid in a protein 
transfer device (MAXI-Semi-Dry-Blotter, Roth). The protein transfer device was 
connected to a power supply (PAC100, Bio-Rad) (200 mA, 2 hours). A transfer blotting 
buffer (Table 2.23) was used to keep the membrane wet. 
 
Table 2.23. 10x transfer blotting buffer. 
Component Concentration (in dH2O) Supplier 
TRIS 250 mM MP Biomedical 
glycine 1.92 M MP Biomedical 
methanol 20% Roth 
 
2.2.8.5 Immune detection 
The nitrocellulose membrane (section 2.2.8.1) was washed with PBS (phosphate buffered 
saline) (Table 2.24) or TBS (TRIS buffered saline) (Table 2.25) and incubated for one hour 
at RT with milk-buffer (4% milk powder in PBS or TBS). The primary antibody (Table 
2.26) was diluted in the milk-buffer. The nitrocellulose membrane was incubated with this 
solution over night at 4°C. The membrane was washed with PBS/0.1% Tween ® 20 (Roth) 
or TBS/1% Tween ® 20 three times for 10 minutes at RT. A horseradish peroxidase 
conjugated secondary antibody (Table 2.27) was diluted in the milk-buffer and the 
nitrocellulose membrane was incubated with this solution for one hour at RT. The 
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nitrocellulose membrane was washed three times for 10 minutes at RT with PBS/0.1% 
Tween ® 20 or TBS/1% Tween ® 20 and twice with PBS or TBS for five minutes at RT. 
Signals from the secondary antibody were detected with the AmershamTM ECLTM Western 
Blotting Analysis System (GE Healthcare Life Sciences). The developing bands were 
analyzed with a gel imaging system (ChemiDoc MP System, Bio-Rad).  
 
Table 2.24. 10x phosphate buffered saline (PBS)*. 
Component Gram Supplier 
NaCl 80 g Roth 
KCl 2 g Merck 
Na2HPO4 14.2 g Fluka 
KH2PO4 2.4 g Oxoid 
*Distilled H2O were used to reach a final volume of one liter.  
 
Table 2.25. 10x TRIS buffered saline (TBS). 
Component Concentration Supplier 
TRIS-HCl (pH 7.4 - 7.6) 500 mM MP Biomedical 
NaCl 1.5 M Roth 
 
Table 2.26. Primary antibodies. 
Primary antibody Origin Dilution Supplier 
anti-GST mouse 1:1.000 Sigma 
anti-M45 mouse 1:1.000 Genovoc AG 
anti-SidCLlo rabbit 1:2.000 affinity purified [3] 
anti-SidCLpn rabbit 1:2.000 affinity purified [80] 
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Table 2.27. Secondary antibodies. 
Secondary antibody Origin Label Dilution Supplier 
anti-mouse IgG  goat HRPO 1:5.000 Sigma 
anti-rabbit IgG  goat HRPO 1:5.000 GE Healthcare 
 
2.2.9 Protein purification 
2.2.9.1 Protein production from E. coli 
A plasmid was transformed into BL21 (DE3) E. coli (sections 2.1.1, 2.2.2.3 and 2.2.2.4). 
LB broth medium harbouring the necessary antibiotic was inoculated with an E. coli 
colony and cultivated over night at 37°C on a shaker. 1 L LB broth medium was inoculated 
with the preparatory culture (OD600 of 0.05). The culture was grown to an OD600 of 0.5 to 
0.8, 1 mM IPTG was added to the medium and the culture was cultivated at 30°C or 37°C 
for two to three hours. The cells were harvested (8.000 x g, 15 minutes, 4°C) and washed 
once with PBS or TBS (3.350 x g, 15 minutes, 4°C). The bacterial pellet was frozen in 
liquid nitrogen and stored at -80°C. 
 
2.2.9.2 Protein purification of His6-conjugated proteins  
The bacterial pellet of BL21 (DE3) E. coli transformed with pSD01 (sections 2.1.1, 2.1.3 
and 2.2.9.1) was thawed on ice. 10 ml lysis buffer (Table 2.28) was used to resuspend the 
bacterial pellet. 1 mg ml-1 lysozyme was added to the solution and incubated for                       
30 minutes. The bacteria were destroyed by passaging through a French Press three times 
with 1000 pound-force per square inch (psi). The suspension was centrifuged (3.350 x g, 
10 minutes, 4°C). 1 ml 50% Ni-NTA-agarose beads (Quiagen) were washed with 10 ml 
washing buffer (Table 2.29) (600 x g, 5 minutes, 4°C). The beads were incubated for one 
hour at 4°C on a rotating wheel with 5 ml of the bacterial supernatant. The beads were 
washed three times with 10 ml washing buffer (600 x g, 5 minutes, 4°C). 0.5 ml of an 
elution buffer (Table 2.30) was incubated for 30 minutes with the beads on a rotating 
wheel at 4°C. The beads were centrifuged (600 x g, 5 minutes, 4°C), the supernatant was 
collected and dialyzed with dialysis buffer (Table 2.31). The protein concentration was 
measured with a spectrophotometer. The samples were frozen in liquid nitrogen and stored 
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at -80°C. Samples of the lysate, washing steps and eluate were boiled with SDS sample 
buffer, separated on a SDS gel and stained with Coomassie Brilliant Blue ® 250 (section 
2.2.8.2).  
 
Table 2.28. Lysis buffer*. 
Component Concentration Supplier 
NaH2PO4 50 mM Merck 
NaCl 300 mM Roth 
imidazole 10 mM Biomol 
*The pH was adjusted with NaOH (Merck) to 8.0. 
 
Table 2.29. Washing puffer*. 
Component Concentration Supplier 
NaH2PO4 50 mM Merck 
NaCl 300 mM Roth 
imidazole 20 mM Biomol 
*The pH was adjusted with NaOH to 8.0. 
 
Table 2.30. Elution buffer*. 
Component Concentration Supplier 
NaH2PO4 50 mM Merck 
NaCl 300 mM Roth 
imidazole 250 mM Biomol 
*The pH was adjusted with NaOH to 8.0. 
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Table 2.31. Dialysis buffer. 
Component Concentration Supplier 
HEPES (pH 7.5) 20 mM Gibco 
NaCl 500 mM Roth 
TRIS(2-carboxyethyl) 
phosphine (TCEP) 
1 mM Roth 
 
2.2.9.3 Protein purification of GST-tagged proteins  
Plasmids expressing GST-SidCLlo (pSD07), GST-SidCLlo_1-340 (pSD04), GST-SidCLlo_341-608 
(pSD05), GST-SidCLlo_609-782 (pSD03), GST-SidCLlo_783-969 (pSD06), GST-SidCLpn 
(pCR02), GST-SidCLpn_P4C (pHP056), GST-PHFAPP1 (pGEX-PH_FAPP1), GST-SidCLlo_1-
608-Lpn_609-917, GST-SidCLpn_1-608-Llo_609-969 or GST (pGEX4T-1) (section 2.1.3) were 
transformed in E. coli BL21 (DE3) (section 2.1.1) and protein production was done as 
described (section 2.2.9.1).  
 The pellets were thawed on ice, resuspended in 10 ml TBS and incubated with                  
1 mg ml-1 lysozyme for 30 minutes at 4°C. The bacteria were destroyed using a French 
Press three times with 1000 psi. The suspension was spun down (3.350 x g, 10 minutes, 
4°C). The Glutathione SepharoseTM 4B beads (GE Healthcare) were washed three times 
with 1 ml TBS to remove the ethanol in the sample (600 x g, 5 minutes, 4°C). 1 ml of the 
beads were mixed with the bacterial supernatant and incubated on a rotating wheel at 4°C 
for two hours. The beads were washed three times with TBS. 1 ml elution buffer (Table 
2.32) was added to the beads and incubated for 30 minutes on a rotating wheel at 4°C. The 
beads were spun down (600 x g, 5 minutes, 4°C) and the supernatant was collected. The 
protein amount was measured with a spectrophotometer. The samples were frozen in liquid 
nitrogen and stored at -80°C. The purity of the samples were analysed on a Coomassie 
stained SDS gel (section 2.2.8.2). 
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Table 2.32. Elution buffer*. 
Component Concentration Supplier 
TRIS (pH 8.0) 700 µl MP Biomedical 
glutathione 15 mM Fluka 
*The final volume was adjusted with dH2O to 10 ml.  
 
2.2.10 Production of a SidCLlo antibody 
His6-SidCLlo was produced (section 2.2.9.2) and lyophilized (Alpha1-4, Christ®). 6 mg 
protein was send to the company SeqLab (Goettingen, Germany) and was used to produce 
an antibody against SidCLlo in two rabbits. The final bleeding of the two rabbits was pooled 
and affinity purified. The antibody was tested in a Western blot and an 
immunofluorescence assay. 
 
2.2.11 Phosphoinositide-pulldown 
Legionella was grown in AYE medium (section 2.2.1.1). A 10 ml overnight culture was 
inoculated with an OD600 of 0.1, grown overnight and used to inoculate a 200 ml overnight 
culture. The culture was grown overnight and harvested (8.000 x g, 10 minutes, 4°C). The 
following steps were performed on ice. The bacteria were washed in 10 ml ice cold 
washing buffer (3.350 x g, 5 minutes, 4°C) and 1 mM phenylmethylsulfonyl fluorid 
(PMSF) (Sigma) was added. The bacteria were lysed with a French Press three times with 
1000 psi. The cell solution was centrifuged with low speed (3.350 x g, 10 minutes, 4°C) 
and high speed (86.000 x g, 1 hour, 4°C). 1 ml of the supernatant was mixed with 50 µl of 
PI-coated agarose beads (PIP-BeadTM Sample Pack, Echelon Biosciences Inc., USA)                 
(10 pM PtdIns µl-1 slurry) and incubated overnight at 4°C on a rotating wheel in the dark. 
The beads were washed five times (600 x g, 5 minutes, 4°C) with washing buffer (Table 
2.33). The bound proteins were eluted with 20 µl SDS sample buffer [81]. The protein 
samples were separated by their size over an SDS gel and stained with Coomassie solution 
(section 2.2.8.2). After destaining the SDS gel with a Coomassie destaining solution the 
dominant bands were cut out and send to MALDI-TOF analysis (matrix-assisted laser 
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desorption/ionization-time of flight). In parallel a SDS gel was stained with silver (section 
2.2.8.3). 
 
Table 2.33. Washing solution. 
Component Concentration Supplier 
HEPES (pH 7.4) 10 mM Gibco 
NaCl 150 mM Roth 
 
2.2.12 Protein lipid overlay assay with PIP-strips and PIP-arrays 
“PIP-strips” and “PIP-arrays” (Echelon Biosciences Inc., USA) are nitrocellulose 
membranes on which different PtdIns, PIs and other lipids are bound at 100 pmol/spot 
(“PIP-strips”) or at a two-fold serial dilution (1.56–100 pmol/spot) (“PIP-arrays”). A GST-
tagged protein was diluted in milk-buffer (120 pmol ml-1 milk-buffer) (4% milk powder 
(Roth) and 0.1% Tween ® 20 in TBS) and added to the nitrocellulose membrane. The 
sample was incubated overnight at 4°C on a shaker. The nitrocellulose membrane was 
washed three times for 30 minutes with milk-buffer and incubated afterwards with the 
primary monoclonal anti-GST antibody (Sigma) (section 2.2.8.5) diluted in the same 
buffer. As a secondary antibody a goat anti-mouse peroxidase-labelled antibody (GE 
Healthcare) was used (section 2.2.8.5). The Western blot analysis was done as described 
previously (section 2.2.8.4) [80, 81, 103, 136]. Only the washing time was increased from 
three times 10 minutes to three times 30 minutes to reduce the background signal of the 
antibody. An ECL detection kit was used to visualize the binding of the GST-tagged 
proteins to the samples (section 2.2.8.5). 
 
2.2.13 Infection of phagocytes 
Amoebae or macrophages were seeded in the adequate medium 24 hours before the 
infection took place (section 2.2.3, 2.2.4 and 2.2.5). The medium was exchanged prior to 
the infection in the case the medium contained an antibiotic. The cells were infected with a 
bacterial overnight culture with a specific multiplicity of infection (MOI) (section 2.2.1.1). 
To this end, the bacteria were added to the cells and spun down on the cells (3.350 x g,          
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10 minutes, RT). The cells were incubated at 25°C for D. discoideum, 30°C for                       
A. castellanii and 37°C with 5% CO2 for RAW 264.7 macrophages.  
 
2.2.14 Immunofluorescence 
Cells were seeded (sections 2.2.3, 2.2.4 and 2.2.5) on coverslips (Menzelglaser) coated 
with poly-L-lysine (Sigma) and infected with an overnight culture (section 2.2.1.1). All 
steps were performed at RT except the fixation step. The cells were washed twice with 
SorC (Sörensen phosphate buffer) (Table 2.34) (D. dictyostelium) or PBS (RAW 264.7 
macrophages). The cells were fixed with 250 µl 4% paraformaldehyde (PFA) (Sigma) for 
15 minutes (D. discoideum) or 250 µl methanol for five minutes at -20°C (RAW 264.7 
macrophages). The cells were permeabilized with 0.1% Triton X-100 (Merck) in PBS or 
SorC for 10 minutes. The cells were washed twice with 1% bovine serum albumin (BSA) 
(Albumin fraction V, Roth) in SorC or PBS. The cells were blocked over 30 minutes with 
1% BSA in SorC or PBS and incubated with the primary antibody (Table 2.35) diluted in 
50 µl of the same buffer for one hour. The chamber was kept wet with a nitrocellulose 
membrane bathed in water. The cells were washed three times with 1% BSA in SorC or 
PBS and blocked with the same buffer for 10 minutes. The secondary antibody (Table 
2.36) was diluted in 1% BSA in SorC or PBS and the cells were incubated with the 
solution for 45 minutes. The cells were washed three times with 1% BSA in SorC or PBS 
and three times with SorC or PBS alone. The cover slips were mounted upside down on 
object slides (A. Hartenstein) with 3 µl “Vectashield mounting medium for fluorescence” 
(Vector Laboratories, Inc.). The cover slips were fixed using nail polish. The object slides 
were dried and stored at 4°C in the dark. Images were produced using a Leica SP5 TCS 
confocal laser fluorescence microscope. 
 
Table 2.34. Sörensen phosphate buffer (SorC) [137]*, **. 
Component Concentration Supplier 
Na2HPO4 2 mM Fluka 
KH2PO4 15 mM Oxoid 
CaCl2 x 2H2O 50 µM Merck 
*The final volume was set to one liter with dH2O.  
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**The pH was adjusted with 1M KOH or 1M HCl to 6.0. The solution was autoclaved and 
stored at room temperature. 
 
Table 2.35. Primary antibodies. 
Primary antibody Origin Dilution Supplier 
anti-GST mouse 1:100 Sigma 
anti-SidCLlo rabbit 1:100 affinity purified [3] 
anti-SidCLpn rabbit 1:100 affinity purified [80] 
 
Table 2.36. Secondary antibodies. 
Secondary 
antibody 
Origin Label Dilution Supplier 
anti-mouse IgG  goat Cy5 1:200 Jackson 
anti-rabbit IgG goat Cy5 1:200 Invitrogen 
 
2.2.15 Detection of PtdIns(4)P on the LCV 
Calnexin-GFP producing D. discoideum Ax3 were infected with the indicated MOI for                
1 hour with red fluorescent L. pneumophila (section 2.1.3) at 25°C. The cells were washed 
with SorC and homogenized with a ball homogenizer [80, 103]. The samples were spun 
down (500 x g, 10 minutes, RT) and fixed with 4% PFA on cover slips coated with poly-L-
lysine. The samples were incubated with purified GST-SidCLlo_P4C (pSD03), GST-SidCLpn-
_P4C (pHP056), GST-PHFAPP1 (pGEX-PH_FAPP1) or GST (pGEX4T-1) (sections 2.1.3 and 
2.2.9.3) for 15 minutes at RT. An immunofluorescence staining was performed with an 
anti-GST antibody (Sigma) (section 2.2.14). As a secondary antibody a Cy5-coupled anti-
mouse antibody (Jackson) was used (section 2.2.14). Pictures were acquired using a Leica 
SP5 TCS confocal laser fluorescence microscope. 
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2.2.16 Intracellular replication assay 
2.2.16.1 D. discoideum 
The cells were seeded in a 96well plate in SorC with 105 cells per well (section 2.2.3). The 
Legionella culture was diluted in MB-medium (Table 2.37) and the cells were infected 
with a MOI of 0.01 (section 2.2.13). The bacteria were spun down (3.350 x g, 10 minutes, 
RT) and incubated for 10 minutes at 25°C. Input-controls were plated out in triplicates on 
CYE plates. 10 minutes, two days, four days and six days post infection the supernatants of 
the cells were collected, diluted in dH2O and plated on CYE plates in triplicate. Colonies 
were counted after three days of incubation at 37°C. 
 
Table 2.37. MB medium [138]*, **. 
Component Gram  Supplier 
Bacto yeast extract 7 g BD Biosciences 
bacteriological peptone 14 g BD Biosciences 
MES sodium salt 4.26 g Sigma 
*The final volume of one liter was reached through adding dH2O.  
**The pH was adjusted with 1 M KOH or 1 M HCl to 6.9. The solution was autoclaved 
and stored at 4°C. 
 
2.2.16.2 A. castellanii 
A. castellanii were seeded in 96well plates (5 x 104 per well) in PYG medium (section 
2.2.4.1) and incubated for one hour at 23°C. The medium was exchanged against Ac buffer 
(Table 2.38). The Legionella overnight culture was diluted in Ac buffer. The cells were 
infected with an MOI of 0.1. The bacteria were spun down (3.350 x g, 10 minutes, RT) and 
incubated for 20 minutes at 30°C. Input controls were plated out on CYE plates in 
triplicate. For the time point zero (20 minutes post infection), one day, two days and three 
days the supernatants of the cells were collected, diluted in Ac buffer and plated on CYE 
plates in triplicate. Colonies were counted after three days incubation at 37°C. 
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Table 2.38. Ac buffer*. 
Component Concentration Supplier 
MgSO4 x 7H2O [0.4 M] 1 ml Merck 
CaCl2 [0.05 M] 0.8 ml Merck 
sodium citrate x 2H2O [1 M] 0.34 ml Roth 
Fe(NH4)2(SO4)2 x 6H2O 2 mg Fluka 
Na2HPO4 x 7H2O [0.25 M] 1 ml Fluka 
KH2PO4 [0.25 M] 1 ml Oxoid 
dH2O 95 ml --- 
*The pH was adjusted to 6.5 with HCl (Roth). The buffer was autoclaved and stored at 
4°C. 
 
2.2.16.3 RAW 264.7 macrophages 
RAW 264.7 macrophages (2 x 104 per well) were seeded in RPMI 1640 medium 
supplemented with 10% FCS and L-glutamine in a 96well plate one day prior to the 
infection (section 2.2.5.1). The Legionella overnight cultures were diluted in RPMI 1640 
medium. The cells were infected (MOI of 0.1) and the bacteria were spun down (3.350 x g, 
10 minutes, RT) on the cells (section 2.2.13). The cells were incubated at 37°C with 5% 
CO2. Input-controls were plated out in triplicate on CYE plates. At time point zero (10 
minutes post infection), one day, two days and three days the supernatants of the cells were 
collected, diluted in dH2O and plated out in triplicate on CYE plates. Colonies were 
counted after three days of incubation at 37°C. 
 
2.2.17 Amoebae competition assay 
The assay was performed as described before [139]. Briefly, A. castellanii were seeded in a 
96well plate one hour prior to the experiment and incubated at 30°C. For each bacterium 
three wells were seeded for each time point. The medium was exchanged against Ac 
buffer. Legionella overnight cultures were diluted in Ac buffer and used to infect the cells 
(MOI of 0.05) (section 2.2.13). The cells were incubated at 30°C for one hour. The Ac 
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buffer was exchanged. Input controls were plated out on CYE plates with and without 
antibiotics in duplicate. Three days after infection the supernatant of the infected cells was 
collected. The cells were lysed with 0.8% saponin (Sigma) for 10 minutes. The supernatant 
and the homogenate were mixed. The solution was diluted 1:1.000 in Ac buffer and 50 µl 
were used to infect freshly seeded amoebae. The remaining solution was diluted in Ac 
buffer and plated out in duplicates with and without antibiotics. The colony forming units 
(cfu) were counted after an incubation time of three days at 37°C. 
 
2.2.18 Translocation assay 
2.5 x 105 RAW 264.7 macrophages were seeded in 24well plates one day prior to the 
experiment (section 2.2.5.1). The cells were infected with a bacterial overnight culture with 
a MOI of 50 in RMPI 1640 medium supplemented with L-glutamine and FCS (section 
2.2.13). The cells were incubated for one hour at 37°C wit 5% CO2. The medium was 
discarded and the cells were lysed with 110 µl dH2O or with the lysis buffer offered by the 
company (Amersham cAMP Biotrak Enzymeimmunoassay (EIA) System, GE Healthcare 
Life Sciences). The assay was performed as described in the manual of the detection kit. 
The final reaction was measured in a plate reader at 450 nm.  
 
2.2.19 LCV purification 
The LCV purification from phagocytes has been done as published previously [2, 54, 140, 
141]. Briefly, calnexin-GFP producing D. discoideum or RAW 264.7 macrophages were 
grown to approximately 80% confluence in a 75 cm² flask (sections 2.2.3.1 and 2.2.5.1). 
The cells were infected with an overnight culture of a Dsred expressing bacteria (section 
2.2.13). The cells were incubated at 25°C for D. discoideum or 37°C with 5% CO2 for 
RAW 264.7 macrophages for one hour. For each purification three flasks were needed. The 
cells were washed three times with SorC for D. discoideum or PBS for RAW 264.7 
macrophages and were resuspended in 3 ml HB-buffer (Table 2.39) using a cell scraper. 
The washing step for D. discoideum was omitted in later experiments. The cells were 
homogenized with a ball homogenizer using an exclusion size of 8 µm. 2% FCS were used 
to block the cell homogenate for 30 minutes at 4°C on a rocking platform. The cell 
suspension was incubated with an anti-SidCLpn or anti-SidCLlo antibody (dilution 1:3.000) 
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for one hour at 4°C on a rocking platform (“homogenate” sample). The suspension was 
centrifuged (2.700 x g, 15 minutes, 4°C) and the pellet was resuspended in HB-buffer 
(“pellet” sample). MACS anti-rabbit antibodies were added to the suspension and 
incubated with the suspension for 30 minutes at 4°C. A MACS-MS separation column 
(Miltenyi Biotec) was put on a magnetic separator MACS Multistand (Miltenyi Biotec) 
and the column was equilibrated with HB-buffer. The sample was applied to the MACS 
columns (“flow through” sample) and the column was washed three times with HB-buffer. 
The MACS columns were removed from the magnetic separator MACS Multistand and the 
probe were eluted with HB-buffer by squirting (“eluate” sample). A density gradient was 
produced with 5.5 ml of 35% Histodenz (Sigma) (in PBS) coated with 5.5 ml of 10% 
Histodenz (in PBS) in a 15 ml tube. The tube was carefully laid down for one hour to allow 
an establishing of the gradient. The sample from the column was added slowly to the 
gradient. The gradient was centrifuged (3.350 x g, 1 hour, 4°C). Eight 1.5 ml fractions 
were taken with a long Pasteur pipette beginning from the bottom (“fraction 1”). The 
fractions were pipetted on a cover slide coated with poly-L-lysine and were centrifuged 
(3.350 x g, 10 minutes, 4°C). The samples were fixed and analyzed by immuno-
fluorescence labeling with an anti-SidCLlo or anti-SidCLpn primary antibody (section 
2.2.14). 
 
Table 2.39. HB buffer*. 
Component Concentration Supplier 
HEPES 20 mM Gibco 
sucrose 250 mM Sigma 
ethylenglycol-bis(aminoethylether)-N, 
N, N’, N’-tetra acetic acid (EGTA) 
0.5 mM AppliChem 
*The pH was set to 7.2 with 1 M NaOH or 1 M HCl. The buffer was sterile filtered and 
stored at 4°C. 
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2.2.20 Cytotoxicity assay 
D. discoideum Ax3 were seeded in a 24well plate (2 x 105 cells per well) one day prior to 
the infection (section 2.2.3.1). The cells were infected with a bacterial overnight culture 
and incubated for 1 hour at 25°C (section 2.2.13). The cells were detached with pipetting 
up and down with a blue tip of a pipette for 10 times. The cell suspension was centrifuged 
(500 x g, 3 minutes, RT) and the supernatant was discarded. The cells were resuspended in 
SorC and 2.5 µg ml-1 propidium iodide was added. The propidium iodide staining was 
measured with a FACS machine. 
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3. Results  
3.1 The L. longbeachae Icm/Dot substrate SidCLlo 
The putative Icm/Dot substrate SidCLlo was identified in the genome of L. longbeachae 
NSW150 as one of the 44% of Icm/Dot substrates which L. longbeachae shares with                
L. pneumophila [26]. This study aimed at investigating the role of SidCLlo in the infection 
of L. longbeachae. 
SidCLpn is an Icm/Dot-dependent effector protein and binds with a P4C domain to 
PtdIns(4)P and to a lower extent to PtdIns(3)P [80, 84, 101]. Other effector proteins like 
SidM compete with SidCLpn for binding to PtdIns(4)P [81]. SidCLpn has a paralog called 
SdcALpn which shares a sequence identity with SidCLpn of 72% [50]. SidCLpn and SdcALpn 
are necessary for the acquisition of ER-derived vesicles [103]. No gene for sdcA was found 
in the genome of L. longbeachae [26]. 
 
3.1.1 The L. longbeachae effector SidCLlo is the major PtdIns(4)P binding protein 
In a previous study L. pneumophila lysate was incubated with agarose beads coupled to 
different PIs. Only the Icm/Dot-dependent effector SidM but not SidCLpn was found to bind 
to PtdIns(4)P [81]. To identify a putative L. longbeachae protein which binds to PtdIns or 
a PI lipid, the phosphoinositide-pulldown assay (section 2.2.11) was adopted. In the 
phosphoinositide-pulldown five dominant protein bands appeared in a Coomassie stained 
gel (Figure 3.1C) and were cut out. The samples were analysed by MALDI TOF mass 
spectrometry (MS). As a control experiment L. pneumophila lysate was incubated with 
PtdIns- or PtdIns(4)P-coupled beads. A band at the size of SidM was detected (Figure 3.B 
and D).  
MALDI TOF analysis revealed that SidCLlo was the major PtdIns(4)P binding protein of                   
L. longbeachae (Figure 3.1A and C, marked with * or 2). SidM was not found in the 
phosphoinositide-pulldown with L. longbeachae (Figure 3.1A and C), in agreement with 
the finding that SidM is missing in the genome of L. longbeachae [26]. Also two acyl CoA 
carboxylases were found which bind to the beads and PtdIns(3,4,5)P3 (Figure 3.1C, 
marked with 1, 5). A heat shock protein 90 and an elongation factor Tu were pulled down 
with PtdIns(4,5)P2 (Figure 3.1C, marked with 3 and 4). In the control experiment a protein 
3. Results 
 
50 
 
of the size of SidM was pulled down with L. pneumophila lysate (Figure 3.1B and D, 
marked with * or 6).  
 
 
Figure 3.1. SidCLlo is the major PtdIns(4)P binding protein of L. longbeachae. Bacterial lysate from                
L. longbeachae (A, C) and L. pneumophila (B, D) wild-type strains were incubated with agarose beads 
coated with PtdIns or various PIs. The beads were washed and the proteins were separated by SDS-PAGE. 
The SDS gels were stained with silver (A, B) or Coomassie (C, D). In a mass spectrometry analysis the               
111 kDa L. longbeachae SidCLlo was identified to bind to PtdIns(4)P (*, 2). Acyl CoA carboxylase (1, 5), 
heat shock protein 90 (3) and elongation factor Tu (4) were also identified. In the control experiment with                               
L. pneumophila lysate a band in the size of 73 kDa appeared. This could be SidM (*, 6).The experiment has 
been done in triplicate [3].  
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3.1.2 SidCLlo is binding through a P4C domain to PtdIns(4)P 
In the next step we analysed the binding domain of SidCLlo. To this end, GST was coupled 
to the N-terminus of SidCLlo, SidCLlo_1-340, SidCLlo_341-608, SidCLlo_609-782 and SidCLlo_783-969 
(Figure 3.2A). The proteins were produced in E. coli, purified and incubated with 
commercially available “PIP-strips” as described previously [80, 81, 103, 136] (Figure 
3.2B) (section 2.2.12). “PIP-strips” are nitrocellulose membranes on which PtdIns, PIs or 
other lipids are bound (100 pmol/spot). The full-length GST-SidCLlo and the GST-
SidCLlo_609-782 fragment bound to PtdIns(4)P (Figure 3.2B). Thus, the PtdIns(4)P binding 
domain of SidCLlo was narrowed down to the amino acids 609 to 782. The previously 
found PtdIns(4)P-binding domain of SidCLpn_P4C is located in the amino acid region of 609 
to 776 [103]. Therefore, we termed the PtdIns(4)P-binding domain of SidCLlo SidCLlo_P4C.   
In the next step the binding affinity of SidCLlo, SidCLlo_P4C, SidCLpn and SidCLpn_P4C 
were compared in an assay using “PIP-arrays” in which PtdIns or PIs are spotted in two-
fold serial dilution on a nitrocellulose membrane. SidCLlo as well as SidCLlo_P4C bound 
strongly to PtdIns(4)P and weakly to PtdIns(3)P. The binding affinity of SidCLlo_P4C to 
PtdIns(4)P appeared higher than the binding affinity of the full length SidCLlo (Figure 
3.2C). In contrast, SidCLpn bound only weakly to PtdIns(4)P. In previously published 
experiments SidCLpn bound to PtdIns(4)P and to a lower extent also to PtdIns(3)P [80, 
103]. In this assay we used harsher washing conditions to reduce the background signal. 
This reduced the amount of SidCLpn bound to PtdIns(4)P and PtdIns(3)P. SidCLpn_P4C 
bound with seemingly higher affinity to PtdIns(4)P than SidCLlo_P4C. The P4C domain of 
SidCLpn also bound weakly to PtdIns(3)P (Figure 3.2C).  
Afterwards the influence of the first 608 amino acids on the binding affinity of the P4C 
domains of L. longbeachae and L. pneumophila were tested. To this end chimera proteins 
consisting of the first 608 amino acids of L. longbeachae and the amino acids 609 to 917 of 
L. pneumophila were purified (SidCLlo_N-Lpn_C). Also chimera proteins consisting of the 
first 608 amino acids of L. pneumophila fused to the amino acids 609 to 969 of                          
L. longbeachae were purified (SidCLpn_N-Llo_C). The two chimera proteins were compared 
with SidCLlo and SidCLpn using PIP-strips (Figure 3.2D) and PIP-arrays (Figure 3.2E). The  
SidCLlo_N-Lpn_C chimera protein and SidCLlo bound equally with high affinity to PtdIns(4)P. 
The binding affinity of SidCLpn_N-Llo_C to PtdIns(4)P was slightly lower compared to 
SidCLlo_N-Lpn_C and SidCLlo (Figures 3.2D and E). Both chimera proteins and SidCLlo bound 
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with low affinity to PtdIns(3)P. A binding of SidCLpn to PtdIns(3)P or PtdIns(4)P was not 
detected (Figures 3.2C and D). 
In summary, SidCLlo was identified as the first PtdIns(4)P-binding protein of                              
L. longbeachae. The P4C domain of this protein is located in a similar C-terminal region as 
SidCLpn_P4C [3]. 
An alignment of SidCLlo, SidCLpn and its paralogous protein SdcALpn was made (Figure 
3.3) to analyse if the amino acid composition could be the reason for the different apparent 
binding affinities of SidCLlo and SidCLpn to PtdIns(4)P. SidCLpn and SdcALpn showed a 
sequence identity of 72%. SidCLpn as well as SdcALpn showed a sequence identity of only 
40% to SidCLlo. The P4C domains of SidCLlo and SidCLpn are located nearly in the same 
amino acid region but the sequence identity of these two P4C domains was only 45%. 
Therefore, the difference in the amino acid composition could be the reason for the 
differences in the binding affinity of SidCLlo and SidCLpn to PtdIns(4)P. 
Despite of a sequence identity of 40% (Figure 3.3) between SidCLlo and SidCLpn, we 
were not able to detect SidCLlo in a Western blot analysis (Figure 3.4) nor in an 
immunofluorescence assay (data not shown) with a polyclonal anti-SidCLpn antibody [80].  
Therefore, a polyclonal anti-SidCLlo antibody using His6-SidCLlo was produced by a 
company (SeqLab). The antibody recognized endogenous SidCLlo in L. longbeachae wild-
type NSW150 as well as SidCLlo produced in L. pneumophila JR32. The anti-SidCLpn 
antibody only recognized endogenous SidCLpn and SidCLpn produced in L. longbeachae 
wild-type. No cross reaction was visible (Figure 3.4) [3].  
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Figure 3.2. SidCLlo binds in vitro through a P4C domain to PtdIns(4)P. Fragments of the 111 kDa SidCLlo 
and the 106 kDa SidCLpn were fused to a GST-tag (A) [103]. The binding affinities of purified GST-SidCLlo 
protein, GST-SidCLlo fragments, GST-SidCLlo_N-Lpn_C and GST-SidCLpn_N-Llo_C (B, D) to PtdIns, PIs or 
different lipids (100 pmol/spot) were analysed in protein-lipid overlay assays. The binding of the GST-
coupled proteins were analysed using an anti-GST antibody. In the left row lysophosphatidic acid (LPA), 
lysophosphocholine (LPC), phosphatidylinositol (PtdIns), phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC) are visible. The right row shows sphingosine-1-phosphate (S1P), 
phosphatidylinositol (PtdIns), phosphatidic acid (PA), phosphatidylserine (PS) and a blank spot (Blank). The 
binding affinities of GST-SidCLlo, GST-SidCLlo_P4C, GST-SidCLpn, GST-SidCLpn_P4C, GST-SidCLlo_N-Lpn_C and 
GST-SidCLpn_N-Llo_C were compared using protein-lipid overlay assays with a two-fold serial dilution (1.56–
100 pmol/spot) (C, E). In two or three independent experiments similar results were achieved [3].  
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Figure 3.3. Comparison of the primary sequence of SidCLlo, SidCLpn and SdcALpn. SidCLlo, SidCLpn and 
SdcALpn were aligned using the amino acid sequence and a ClustalOmega algorithm. SidCLlo is 40% identical 
to SidCLpn or SdcALpn. The P4C domains of SidCLlo (red) and SidCLpn (blue) share 45% identity. SidCLpn and 
SdcALpn are 72% identical. Similar (grey) or identical (black) amino acids are labelled. The figure is adapted 
from a scheme published in [3]. 
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Figure 3.4. Anti-SidCLlo and anti-SidCLpn antibodies recognize only their cognate proteins.                        
L. longbeachae wild-type and L. pneumophila wild-type were grown in overnight cultures. M45-SidCLlo 
(pSD13) or M45-SidCLpn (pCR34) were transformed and induced in L. pneumophila or L. longbeachae. The 
same amount of bacteria was boiled in SDS sample buffer. The proteins were separated by SDS-PAGE and 
visualized by Western blot using specific polyclonal rabbit anti-SidCLlo and anti-SidCLpn antibodies. The 
experiment was repeated three times with the same results [3].  
 
3.1.3 The Icm/Dot substrate SidCLlo localizes to LCVs  
To test the Icm/Dot-dependent translocation of SidCLlo an enzyme immunoassay kit 
(Amersham cAMP Biotrak Enzymeimmunoassay (EIA) System, GE Healthcare Life 
Sciences) was used. In this assay, the calmodulin-dependent production of cAMP by 
adenylate cyclase (CyaA) in the host cell cytoplasma is assessed. L. longbeachae [30] as 
well as L. pneumophila [48] are able to infect macrophages. Therefore, RAW 264.7 
macrophages were infected with L. longbeachae or L. pneumophila harbouring plasmid-
encoded CyaA, CyaA-SidCLlo or CyaA-SidCLpn. CyaA as well as dotA deletion mutants of 
L. longbeachae and L. pneumophila were used as negative controls. CyaA was not 
translocated in all strains. All proteins were not translocated in the dotA deletion mutants 
of both strains. We used CyaA-SidCLpn as a positive control. SidCLpn was translocated in  
L. pneumophila, but no translocation was visible in L. longbeachae. SidCLlo was neither 
translocated by L. longbeachae nor by L. pneumophila (Figure 3.5A). Therefore, the 
protein production was analyzed. The endogenous SidCLpn and the ~145 kDa CyaA-
SidCLpn were produced in L. pneumophila. The ~151 kDa CyaA-SidCLlo was produced 
with the expected size in L. pneumophila. A small band in the size of SidCLlo alone was 
also detected. In the L. longbeachae samples it seemed as if parts of the CyaA or the whole 
CyaA were cleaved from SidCLlo or SidCLpn because the detected bands were between the 
expected size for the CyaA-coupled proteins and the full-length proteins (Figure 3.5B).  
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Next, a published L. longbeachae effector protein was used as a positive control. CyaA-
CetLI1 (C-terminal signal for effector translocation of L. longbeachae 1) was previously 
published to be translocated in an Icm/Dot-dependent way in HL-60-derived human 
macrophages when overexpressed in L. pneumophila [58]. Therefore, we transformed 
CyaA-CetLI1 [58] into L. longbeachae and L. pneumophila. DotA deletion mutants were 
used as negative controls. Yet, CyaA-CetLI1 was only translocated in L. pneumophila 
wild-type but not in wild-type L. longbeachae (Figure 3.5C). Changing the amount of cells 
and the lysis method used for this assay had no effect on the detection of translocation. 
Therefore, we decided to use an immunofluorescence approach to analyze if SidCLlo is 
translocated in an Icm/Dot-dependent manner. 
 
 
Figure 3.5. Measurement of translocation of SidCLlo. RAW 264.7 macrophages were infected with                    
L. longbeachae or L. pneumophila wild-type as well as with a dotA mutant expressing CyaA (pSH097), 
CyaA-SidCLpn (pSH098) or CyaA-SidCLlo (pIH031). The translocation of the proteins was measured by the 
cAMP level. Means and standard deviations were calculated from two independent samples. The experiment 
has been done once (A). Overnight cultures were boiled, separated by SDS-PAGE and the proteins were 
visualized by specific anti-SidC antibodies. Between one and three overnight cultures were analyzed per 
sample (B). The cAMP translocation of CetLI1 in a wild-type or a dotA mutant of L. longbeachae and                  
L. pneumophila was analyzed three times with different lysis methods. Means and standard deviations were 
calculated from two independent samples (C). 
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RAW 264.7 macrophages were infected with L. longbeachae wild-type or a ∆dotA 
mutant harbouring a Dsred-producing plasmid or a plasmid coding for Dsred and SidCLpn. 
Endogenous SidCLlo and overproduced SidCLpn were visualized using specific anti-SidC 
antibodies. An immunofluorescence analysis of the infected macrophages showed a 
localization of SidCLlo and SidCLpn on the LCV membrane (Figure 3.6A). 48% of the 
endogenous SidCLlo and 56% of the overexpressed SidCLpn co-localized to the LCV 
membrane. Only less than 1% of the LCVs infected with a dotA deletion mutant were 
positive for SidCLlo or SidCLpn (Figure 3.6B). Therefore, the translocation of SidCLlo and 
SidCLpn to the surface of the L. longbeachae-containing vacuole is Icm/Dot-dependent. It 
seems as if the L. longbeachae T4SS translocates both SidC proteins with similar 
efficiencies. 
 
 
Figure 3.6. SidCLlo is an 
Icm/Dot-dependent 
effector protein which 
localizes to the LCV. 
RAW 264.7 macrophages 
were infected (MOI 50,               
1 hour) with wild-type or a 
dotA deletion mutant of               
L. longbeachae harbouring 
a Dsred-encoding plasmid 
(pCR77) or a plasmid-
encoding Dsred and SidCLpn 
(pCR80). The endogenous 
SidCLlo and the over-
expressed SidCLpn were 
stained with a specific anti-
SidC antibody (light blue). 
The nucleus was stained 
with DAPI (dark blue) (bar 
=  5µm) (A). The SidCLlo 
and SidCLpn positive LCVs 
were counted. The mean 
and standard deviations 
were calculated from three 
independent experiments 
with 50 LCV each (** 
p<0.01) (B) [3].  
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3.1.4 The ∆sidCLlo and ∆sidC-sdcALpn deletion mutants are outcompeted by the wild-
type strains in competition assays 
The role of SidCLlo on the intracellular replication of L. longbeachae in infected amoebae 
or macrophages was analysed. To this end, a defined sidCLlo deletion mutant was used 
(strain IH02) [3].  
We infected A. castellanii or RAW 264.7 macrophages with wild-type L. longbeachae 
(NSW150), a dotA and a sidCLlo deletion strain. L. longbeachae wild-type as well as the 
sidCLlo deletion mutant grew equally. Over 3 days of infection both strains grew with 
similar rates, producing two (Figure 3.7B) or three (Figure 3.7A) orders of magnitude more 
bacteria. The L. longbeachae dotA deletion mutant was not able to grow intracellularly in 
A. castellanii or RAW 264.7 macrophages, as published before (Figure 3.7) [26]. 
Therefore, SidCLlo is not necessary for the intracellular growth of L. longbeachae in                  
A. castellanii or RAW 264.7 macrophages. 
 
 
Figure 3.7. L. longbeachae lacking sidCLlo grows normally in RAW 264.7 macrophages and                           
A. castellanii. A. castellanii (A) or RAW 264.7 macrophages (B) were infected (MOI 0.1) with                             
L. longbeachae wild-type NSW150, a dotA or a sidCLlo deletion mutant. Supernatants of the infected cells 
were taken shortly after infection (time point 0) and 1 day, 2 days and 3 days after the infection and plated on 
CYE plates. The colony forming units (cfus) were counted [3].  
 
In an alternative approach, A. castellanii were co-infected with L. longbeachae wild-
type and the sidCLlo deletion mutant, or with L. pneumophila and the sidC-sdcALpn deletion 
mutant. The sidCLlo deletion mutant disappeared in direct competition with its wild-type 
strain within 24 days (Figure 3.8A). In parallel, the normal growth of both strains alone in                      
A. castellanii was confirmed (Figure 3.8C). The sidC-sdcALpn deletion strain died already 
within 12 days in direct competition with its wild-type strain (Figure 3.8B). In a single 
strain infection assay both strains grew normally (Figure 3.8D). Taken together, in direct 
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competition the wild-type strains of L. longbeachae and L. pneumophila outcompete the 
corresponding sidC mutant strains in A. castellanii.  
 
 
Figure 3.8. L. longbeachae and L. pneumophila wild-type strains outcompete the ∆sidCLlo and ∆sidC-
sdcALpn strains. A. castellanii were co-infected (MOI 0.01) with L. longbeachae wild-type and a ∆sidCLlo 
deletion mutant (A) or with L. pneumophila wild-type and a ∆sidC-sdcALpn deletion mutant (B). The infected 
amoebae and the supernatant was diluted 1:1.000 every third day and a newly seeded layer of amoeba was 
infected. The colony forming units were counted at the time points indicated. In parallel A. castellanii were 
infected alone with L. longbeachae (C) or L. pneumophila strains (D). The experiment was done in triplicate. 
The standard deviations were calculated from three independent infections plated in duplicate [3]. 
 
3.1.5  SidCLlo and SidCLpn promote ER recruitment to the LCV 
The ability of L. longbeachae to infect D. discoideum Ax3 was tested. To this end, we 
infected the cells with L. longbeachae wild-type or a dotA deletion mutant. The 
corresponding strains of L. pneumophila were used as a control (Figure 3.9).                                
L. longbeachae replicated less efficiently in D. discoideum than L. pneumophila within 6 
days. Both dotA deletion mutants were not able to grow intracellularly. L. longbeachae is 
infecting D. discoideum but grows slower in D. discoideum than L. pneumophila. 
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Next, the role of SidCLlo in the ER recruitment to the L. longbeachae-containing 
vacuole was analysed. Calnexin-GFP D. discoideum rounded up and detached right after 
the infection with L. longbeachae wild-type. Therefore, the infected cells were lost during 
the infection and immunofluorescence labelling was difficult.  
To analyse this phenomenon in more detail, calnexin-GFP producing D. discoideum 
were infected with L. longbeachae wild-type and a dotA deletion mutant producing Dsred. 
The bacteria were spun onto the cells, infected for 1 hour and the cells were fixed without 
previously washing. After infection with wild-type L. longbeachae, many calnexin-GFP      
D. discoideum were lost compared to an infection with a dotA deletion mutant of                        
L. longbeachae. Therefore, this effect is Icm/Dot-dependent (Figure 3.10).  
 
 
 
The change in D. discoideum morphology could be due to a cytotoxic effect of                      
L. longbeachae. Therefore, the cytotoxicity of L. longbeachae towards D. discoideum was 
tested. D. discoideum were infected with L. longbeachae and L. pneumophila wild-type 
and a corresponding dotA deletion mutant. Cytotoxicity of wild-type L. longbeachae or 
wild-type L. pneumophila was low (< 8%) and the dotA mutants of L. longbeachae and               
L. pneumophila had no cytotoxic effect on D. discoideum. The cytotoxic effect of                     
Figure 3.9. Intracellular replication of     
L. longbeachae and L. pneumophila in                    
D. discoideum.  D. discoideum Ax3 were 
infected (MOI 0.01) with L. longbeachae or                
L. pneumophila wild-type or a corresponding 
dotA deletion mutant at 25.5°C. The supernatant 
of the cells was collected every second day and 
plated on CYE plates. The cfus were counted. 
The means and standard deviations of infections 
done in triplicate are shown. The experiment 
was done three times. 
Figure 3.10. L. longbeachae wild-type alters the 
cell adherence of calnexin-GFP producing                
D. discoideum. Calnexin-GFP producing                      
D. discoideum (green) were infected (MOI 50) with 
L. longbeachae harbouring a Dsred (red) encoding 
plasmid for 1 hour. The cells were fixed and 
analyzed with a confocal microscope. The 
experiment was done in duplicate (bar = 10 µm). 
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L. longbeachae does not increase with higher MOIs (Figure 3.11). Together,                            
L. longbeachae seems to have no cytotoxic effect on D. discoideum. 
 
 
Figure 3.11. L. longbeachae shows no cytotoxic effect on D. discoideum. D. discoideum were infected 
(MOI 10 and 100) with L. longbeachae wild-type and a dotA mutant as well as with the corresponding                    
L. pneumophila strains for 1 hour. The cells were harvested and the dead cells were stained with propidium 
iodide. The amount of absorbed propidium iodide was measured with a FACS machine. Uninfected cells 
were used as a negative control. Mean and standard deviations of three independent experiments are 
indicated. The experiment was done three times.  
 
Previously published data demonstrated the recruitment of ER to the L. pneumophila-
containing vacuole in calnexin-GFP producing D. discoideum [53, 80, 103, 142]. The ER 
marker calnexin was recruited to a LCV containing L. pneumophila wild-type but not to an 
icmT deletion mutant. Also, the loss of the genes sidCLpn and sdcALpn led to a decreased 
recruitment of calnexin to the LCV. The effect occurred within 1 hour and remained at 
least for four hours. The loss of the ER recruitment was complemented by adding plasmid-
encoded SidCLpn or SdcALpn, but not with adding the C-terminal part of SidCLpn [103]. 
We wanted to test if this effect could be complemented by SidCLlo as well. Therefore, 
we infected calnexin-GFP producing D. discoideum with wild-type, an icmT or a sidC-
sdcALpn deletion mutant of L. pneumophila harbouring the red fluorescent dye Dsred or a 
plasmid-encoding Dsred and SidCLpn or SidCLlo (Figure 3.12A). In 72% of the cases 
calnexin-GFP was recruited to a LCV harbouring wild-type L. pneumophila. After an 
infection with an icmT deletion mutant only 1% of the LCVs were calnexin-GFP positive. 
Also the loss of sidCLpn and sdcALpn led to a decrease in the recruitment of calnexin-GFP to 
the LCV (19%) (Figure 3.12B) as published before [103]. A complementation of this 
decreased calnexin recruitment to the LCV was only possible with SidCLpn as published 
before (78%) [103] but not with overexpressed SidCLlo (14%). Between one and four hours 
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after the infection the calnexin-GFP recruitment did not alter for a L. pneumophila sidC-
sdcALpn deletion mutant which expressed SidCLlo (Figure 3.12C). Noteworthy, these 
immunofluorescence experiments were performed with formaldehyde-fixed cells. 
 
 
Figure 3.12. The calnexin-GFP recruitment to a LCV harbouring a sidC-sdcALpn deletion mutant of           
L. pneumophila is not complemented by SidCLlo. Calnexin-GFP producing D. discoideum were infected 
(MOI 50) with L. pneumophila wild-type, an icmT or a sidC-sdcALpn deletion mutant. The bacteria were 
harbouring a Dsred (pCR77), a Dsred and SidCLpn (pCR80) or a Dsred and SidCLlo (pSD14) expressing 
plasmid. The cells were infected for 1 hour, fixed with paraformaldehyde and analysed with a confocal 
microscope (A) (bar = 5 µm) (Caln. = calnexin). 100 LCVs were counted in three independent experiments 
(*** P<0.001) (B). The calnexin-GFP recruitment was analysed over time (C). 
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To test whether the fixation of the cell affects the calnexin-GFP signal, the same set of           
L. pneumophila strains was analysed with living cells (Figure 3.13). The results for                    
L. pneumophila wild-type, ∆icmT, ∆sidC-sdcALpn and the complementation strain with 
SidCLpn did not alter (Figures 3.12 and 3.13). In contrast, in living cells a complementation 
of the calnexin recruitment defect of a ∆sidC-sdcALpn strain with SidCLlo was visible (64%) 
(Figure 3.12). Thus, the fixation process apparently interfered with the signal 
accumulation. Taken together, the impaired ER recruitment to the L. pneumophila-
containing vacuole can be complemented by the production of SidCLpn, SdcALpn and 
SidCLlo.  
Finally, we used living D. discoideum to analyse the calnexin-GFP recruitment to a                 
L. longbeachae-containing vacuole. A pre-test demonstrated that the calnexin-GFP 
recruitment to the L. longbeachae LCV reaches its saturation after 2 hours post infection. 
Therefore, calnexin-GFP producing D. discoideum were infected for 2 hours with wild-
type, a dotA and a sidCLlo deletion mutant harbouring a Dsred-expressing plasmid. For 
complementation experiments, a sidCLlo deletion mutant was used, which harboured a 
plasmid-encoding for Dsred and SidCLlo, SidCLpn or SdcALpn (Figure 3.14). 82% of the 
LCVs containing wild-type L. longbeachae were calnexin-GFP positive. An infection with 
a dotA deletion mutant produced only 2% calnexin-GFP positive LCVs. This indicates that 
the recruitment of ER derived vesicles to the L. longbeachae-containing vacuole is 
Icm/Dot-dependent. The deletion of the sidCLlo gene led to a decreased calnexin-GFP 
recruitment to the LCV of around 20%. This effect was complemented by adding plasmid-
encoded SidCLlo (80%), SidCLpn (83%) or SdcALpn (74%) (Figure 3.14B).  
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Figure 3.13. The decreased ER recruitment 
to the L. pneumophila ∆sidC-sdcALpn 
containing vacuole in D. discoideum is 
complemented by SidCLlo. Calnexin-GFP                  
D. discoideum were infected (MOI 20, 1 hour) 
with L. pneumophila wild-type, an icmT or a 
sidC-sdcALpn deletion mutant. The strains 
harboured a Dsred (pCR77) or a plasmid 
which produced Dsred and SidCLlo (pSD14) or 
SidCLpn (pCR80). Live cells were imaged with 
a confocal microscope (bar = 5 µm) (A). The 
calnexin-GFP signal of 100 L. longbeachae-
containing vacuoles were counted in two 
independent experiments (* P<0.05) (B) [3].  
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Figure 3.14. L. longbeachae 
SidCLlo is necessary for the ER 
recruitment to the LCV.                    
L. longbeachae wild-type, a dotA or 
a sidCLlo deletion mutant har-
bouring a Dsred expressing plasmid 
(pCR77) were used to infect (MOI 
20) calnexin-GFP producing D. 
discoideum for 2 hours. The sidCLlo 
deletion mutant was complemented 
with a plasmid encoding for Dsred 
and SidCLlo (pSD14), SidCLpn 
(pCR80) or SdcALpn (pIH047). The 
cells were imaged with a confocal 
microscope (bar = 5 µm) (A). The 
calnexin-GFP signal of 100 L. 
longbeachae-containing vacuoles 
were counted in two separate 
experiments (* P<0.05) (B) [3].  
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In summary, we found that the ER recruitment to the LCV of L. longbeachae and                   
L. pneumophila is Icm/Dot-dependent. The loss of the genes sidCLlo as well as sidC-
sdcALpn decreased the ER recruitment to the LCV. These effects can be complemented by 
adding plasmid-encoded SidCLlo, SidCLpn as well as SdcALpn. Therefore, the function of 
SidCLlo, SidCLpn and SdcALpn are redundant. Overall, the amount of calnexin-GFP on the 
LCV is comparable for L. longbeachae as well as L. pneumophila wild-type strains (Figure 
3.13 and 3.14) [103].  
 
3.1.6 SidCLlo_P4C and SidCLpn_P4C are binding to PtdIns(4)P on  the LCV 
We were interested if SidCLlo_P4C and SidCLpn_P4C are localizing to the LCV. Therefore, 
Calnexin-GFP D. discoideum were infected with red fluorescent L. pneumophila for                   
1 hour. The cells were homogenized and incubated with purified GST fusion proteins 
(Figure 3.15A). Less than 1% of the LCVs incubated with the negative control, GST, were 
GST positive. 82% of the LCVs were covered with GST-SidCLlo_P4C. A quantification 
revealed that 88% of the L. pneumophila-containing vacuoles were GST-SidCLpn_P4C 
positive. For the positive control GST-PHFAPP1 77% of the LCVs were GST-PHFAPP1 
positive (Fig. 3.15B). Similar results were published previously for GST-PHFAPP1 [80]. 
Therefore, GST-SidCLlo_P4C binds to LCVs to a similar extent as GST-SidCLpn_P4C and 
GST-PHFAPP1. These findings indicate that both P4C domains can be used as PtdIns(4)P 
binding probes for L. longbeachae or L. pneumophila in all biological experiments. 
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Figure 3.15. SidCLlo_P4C and SidCLpn_P4C binds through PtdIns(4)P to the LCV. Calnexin-GFP producing                   
D. discoideum were infected with red fluorescent L. pneumophila (MOI 100, 1h). The cells were 
homogenised, fixed and the samples were incubated with GST-tagged proteins. An anti-GST antibody was 
used. Images were taken with a confocal microscope (bar = 1 µm) (A). Means and standard deviations from 
three independent experiments are shown, in which 100 LCVs each were counted (** P<0.01, *** P<0.001) 
(B) [3]. 
 
3.2. Purification of LCVs from L. longbeachae   
A protocol for the isolation of L. pneumophila-containing vacuoles from infected                               
D. discoideum was previously published [143]. In this protocol calnexin-GFP producing  
D. discoideum were infected with Dsred expressing L. pneumophila. A cell-free 
homogenate was incubated with an anti-SidCLpn antibody followed by a secondary 
antibody, which was coupled to magnetic beads. The homogenate was run through a 
magnetic separator (Figure 3.16), followed by a density centrifugation step [143].  
 
 
Figure 3.16. Purification of L. pneumophila-
containing vacuoles. Cells were infected with 
Dsred expressing L. pneumophila (red). SidCLpn 
(blue) was translocated through the Icm/Dot T4SS 
(light green) to the surface of the LCV (dark 
green). The LCVs were incubated with an anti-
SidCLpn antibody (black) followed by a secondary 
antibody coupled with a magnetic bead (brown). 
The LCVs were isolated over a magnet (gray). The 
scheme is based on the model previously 
published [1, 2]. 
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Liquid chromatography coupled to tandem mass spectrometry (MS/MS)  was done with 
purified LCVs of L. pneumophila and over 560 host proteins of D. discoideum were 
identified including lipid phosphatases and kinases [143]. A purification method was 
established to purify LCVs from infected RAW 264.7 macrophages. The protocol was 
similar to the protocol used for D. discoideum [2]. Mass spectrometry analysis identified 
over 1150 host proteins on the LCVs of macrophages including members of the Rab family 
[2]. 
These protocols were used as a starting point for the purification of L. longbeachae- 
containing vacuoles from D. discoideum or RAW 264.7 macrophages. To this end, SidCLpn 
was overexpressed in L. longbeachae and an anti-SidCLpn antibody was used for the 
purification. With the newly raised SidCLlo antibody a purification with the endogenous 
SidCLlo and the corresponding SidCLlo antibody was tried as well. The goal was to obtain 
enough purified LCVs from both cell lines to perform a proteome analysis of the                       
L. longbeachae-containing vacuole. 
 
3.2.1 Purification of L. longbeachae-containing vacuoles from D. discoideum with an     
anti-SidCLpn antibody  
For proteomic analysis purified L. longbeachae LCVs were needed. At the beginning of 
this work no specific SidCLlo antibody or any other L. longbeachae specific antibody was 
available which detects a marker of the L. longbeachae-containing vacuole. 
We showed that the anti-SidCLpn antibody [80] does not recognize endogenous SidCLlo 
on the L. longbeachae-containing vacuole in D. discoideum, but after overexpression of 
SidCLpn in L. longbeachae, the antibody recognized SidCLpn on the LCV (Figure 3.17). 
Therefore, we decided to use a L. longbeachae strain harbouring a plasmid coding for 
Dsred and SidCLpn for the LCV purification.  
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Figure 3.17. Overexpressed SidCLpn is covering a L. longbeachae-containing vacuole in infected                      
D. discoideum. D. discoideum were infected (MOI 50) with wild-type L. longbeachae harbouring a Dsred 
encoding plasmid (pSW001) or a plasmid-encoding Dsred and SidCLpn (pCR80) for one hour. The cells were 
fixed and stained with an anti-SidCLpn antibody followed by an anti-rabbit IgG (Cy5) secondary antibody (bar 
= 5 µm). The experiment was performed  twice. 
 
 As a positive control D. discoideum producing calnexin-GFP were infected with Dsred 
expressing L. pneumophila (pSW001) (Figure 3.18). Many calnexin-GFP positive LCVs 
were visible in the homogenate and in the pellet. Bacteria which had not infected the cells 
were not binding to the column and were appearing in the flow through sample. The LCVs 
were collected in the eluate sample. After the Histodenz gradient most of the LCVs were 
found in fraction 4 and some LCVs in fraction 3 (Figure 3.18).  
 D. discoideum Ax3 or calnexin-GFP producing D. discoideum were infected with                 
L. longbeachae producing Dsred and SidCLpn (pCR80) (Figure 3.19). After infection with 
L. longbeachae producing Dsred and SidCLpn the cells detached right after the infection 
(Figure 3.10). Since many cells were lost during the washing step of the infected cells, the 
washing step was omitted in further experiments. The infected cells were homogenized and 
the binding to the column was mediated through an anti-SidCLpn antibody followed by the 
secondary MACS anti-rabbit antibody. LCVs were visible in the homogenate and in the 
pellet sample. After adding the sample to the MACS column it took in most of the 
experiments much longer for the sample to flow through the column than we have seen 
before for the L. pneumophila samples. The flow through contained free bacteria (Figure 
3.19). In the eluate LCVs were found. After the separation step through the Histodenz 
gradient some LCVs were found in fraction 3, 4 and 5. The major amount of LCVs was 
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found in fraction 4 (Figure 3.19) which is comparable with the distribution of LCVs in the 
Histodenz gradient of L. pneumophila [2, 54, 140, 141].  
Throughout this work the yield of isolated LCVs was too small for further proteomic 
analysis. This problem was not solved by omitting the first washing step of the cells or 
through increasing the MOI. Also, a lot of cell debris were left in fraction 4 (Figure 3.19). 
 
 
Figure 3.18. Purification of L. pneumophila-containing vacuoles from D. discoideum. Calnexin-GFP 
producing D. discoideum Ax3 (green) were infected (MOI 50, 1h) with L. pneumophila harbouring Dsred 
(red) on a plasmid (pSW001) at 25°C. The infected cells were homogenized (homogenate), centrifuged 
(pellet) and incubated with an anti-SidCLpn antibody followed by a MACS anti-rabbit antibody. The cell 
suspension was added to the column (flow through) and was eluted with HB-buffer (eluate). The eluate was 
added on a Histodenz gradient, centrifuged and eight fractions were analyzed starting from the bottom of the 
column (fraction 1 to 8). SidCLpn was stained with an anti-SidCLpn antibody (blue). The bar in the large 
pictures denote 10 µm and in the smaller picture 2 µm. The experiment has been done with calnexin-GFP 
producing or unlabeled D. discoideum Ax3 three times. 
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Figure 3.19. Purification of L. longbeachae-containing vacuoles from calnexin-GFP producing                      
D. discoideum. Calnexin-GFP producing D. discoideum Ax3 (green) were infected (MOI 50, 1h) with                   
L. longbeachae harbouring Dsred (red) and SidCLpn on a plasmid (pCR80) at 25°C. A homogenate was 
prepared and the cell suspension was centrifuged (pellet). The cell solution was incubated with an anti-
SidCLpn antibody followed by a MACS anti-rabbit antibody. The LCVs were separated from free bacteria 
with a column (flow through and eluate). A further separation step was done with a Histodenz gradient 
(fraction 1 to 8). All samples were centrifuged on coverslips coated with poly-L-lysine. The overexpressed 
SidCLpn was stained with an anti-SidCLpn antibody (blue). The bar of the big pictures denote 10 µm and of the 
smaller picture 2 µm. The experiment was done twice with wild-type D. discoideum Ax3 or calnexin-GFP 
producing D. discoideum. 
 
3.2.2 Purification of L. longbeachae-containing vacuoles from RAW 264.7 
macrophages  
After realizing that the purification of a L. longbeachae-containing vacuole from                       
D. discoideum does not seem to be possible without extensive alterations of the protocol 
we decided to try to isolate the LCVs from RAW 264.7 macrophages. 
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3.2.2.1 Purification of L. longbeachae-containing vacuoles from RAW 264.7 
macrophages with an anti-SidCLpn antibody  
To this end, we infected RAW 264.7 macrophages with L. longbeachae harbouring a 
plasmid encoding Dsred and SidCLpn. Again as a control experiment RAW 264.7 
macrophages were infected with Dsred expressing L. pneumophila (Figure 3.20).                        
L. pneumophila-containing vacuoles covered by SidCLpn were visible in the homogenate 
and the amount of LCVs was enriched in the pellet. In the flow through no LCVs were 
visible. Small amounts of LCVs were detected in the eluate and in fraction 4 (Figure 3.20). 
 
 
Figure 3.20. Purification of L. pneumophila-containing vacuoles from RAW 264.7 macrophages. Dsred 
expressing L. pneumophila (pSW001) (red) were used to infect RAW 264.7 macrophages (MOI 50) for                   
1 hour at 37°C with 5% CO2. The cells were homogenized. The cell suspension was concentrated by 
centrifugation and was resuspended in a smaller volume of buffer (pellet). An anti-SidCLpn antibody followed 
by a MACS anti-rabbit antibody was used to incubate the cell suspension. This suspension was applied to the 
column (flow through) and was eluted with HB-buffer (eluate). A further separation step was performed with 
a Histodenz gradient. Eight fractions were taken from the gradient starting from the bottom of the column 
(fraction 1 to 8). The samples were fixed on coverslips and the endogenous SidCLpn was stained with an anti-
SidCLpn antibody. The bar of the big pictures denote 10 µm and of the smaller picture 2 µm. The experiment 
was done two times. 
 
After infecting RAW 264.7 macrophages with L. longbeachae harbouring a Dsred- and 
SidCLpn-encoding plasmid the amount of LCVs in the homogenate and the pellet were 
comparable with the amount of LCVs in the L. pneumophila control (Figures 3.20 and 
3.21). Again we observed that the sample applied to the column took much longer to rinse 
through the column than the L. pneumophila samples did before. In the flow through 
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bacteria were visible and in the eluate few LCVs were found. Most of the bacteria 
appeared in fraction four and five whereas the LCVs were located in fraction four. 
However, only few L. longbeachae-containing vacuoles were observed (Figure 3.21). 
 
 
Figure 3.21. Purification of L. longbeachae-containing vacuoles from 264.7 macrophages with an anti-
SidCLpn antibody. RAW 264.7 macrophages were infected (MOI 50, 1h) with L. longbeachae harbouring 
plasmid-encoded Dsred and SidCLpn (pCR80) at 37°C with 5% CO2. After homogenization the cells were 
centrifuged (pellet). The cell suspension was incubated with an anti-SidCLpn antibody followed by a MACS 
anti-rabbit antibody. The cell suspension was run through a column (flow through). The bound sample was 
eluted with HB-buffer (eluate). The eluate was separated with a Histodenz gradient. An analysis of eight 
fractions starting from the bottom of the column (fraction 1 to 8) was performed (bar = 10 µm). After fixing 
the samples on coverslips the samples were stained with an anti-SidCLpn antibody. The bar of the big pictures 
denote 10 µm and of the smaller picture 2 µm. The experiment was done four times. 
 
3.2.2.2 Purification of L. longbeachae-containing vacuoles from RAW 264.7 
macrophages with an anti-SidCLlo antibody  
After generating the new anti-SidCLlo antibody (section 2.2.10) a purification of                   
L. longbeachae-containing vacuoles from infected RAW 264.7 macrophages was tried 
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using wild-type L. longbeachae harbouring a Dsred producing plasmid. The previously 
published protocol for the LCV purification from RAW 264.7 macrophages [2] was not 
changed, other than using the anti-SidCLlo antibody instead of the anti-SidCLpn antibody.  
Compared to a LCV isolation from RAW 264.7 macrophages infected with                                
L. pneumophila using a SidCLpn specific antibody (Figure 3.20), the amount of bacteria and 
also the amount of LCVs in the homogenate and pellet were low. This did not change with 
increasing MOI. In the flow through bacteria were visible. Unfortunately, only bacteria 
without a SidCLlo staining were found in the eluate. Subsequently, the bacteria were found 
in fraction three and four. Taken together, it seems that the purification of a                                 
L. longbeachae-containing vacuole with endogenous SidCLlo is not possible with this 
protocol (Figure 3.22). 
 
 
Figure 3.22. Purification of L. longbeachae-containing vacuoles from RAW 264.7 macrophages with an 
anti-SidCLlo antibody. The cells were infected (MOI 10, 1h) with L. longbeachae harbouring a Dsred-
encoding plasmid (pSW001) at 37°C with 5% CO2. The infected cells were homogenized and the cell 
suspension was centrifuged (pellet). The cell suspension was incubated with an anti-SidCLlo antibody 
followed by a MACS anti-rabbit antibody. The sample was added to a MACS column and the flow through 
was collected (flow through). The sample bound to the MACS column was eluted with HB-buffer. A 
Histodenz gradient was used to further separate the eluate into eight fractions. The fractions were collected 
starting from the bottom of the column (fraction 1 to 8). The samples were fixed on coverslips coated with 
poly-L-lysine and stained with an anti-SidCLlo antibody. The bar of the big pictures denote 10 µm and of the 
smaller picture 2 µm. The experiment was done two times with different MOIs. 
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4. Discussions 
4.1 The L. longbeachae Icm/Dot substrate SidCLlo 
L. longbeachae and L. pneumophila are the causative agents of the Legionnaire’s disease. 
L. pneumophila is well characterized regarding ecological habitat, transmission, 
physiology and effector proteins. In contrast, only little is known about L. longbeachae. 
The aim of this part of the PhD thesis was to analyze the first effector protein, SidCLlo, of 
L. longbeachae. To this end, biochemical and genetic analysis were used. In an unbiased 
phosphoinositide-pulldown L. longbeachae lysate was incubated with PtdIns or different 
PIs. SidCLlo coupled to agarose beads was found to be the major PtdIns(4)P binding protein 
of L. longbeachae. No other effector protein was found, which bound to PtdIns or any PI 
lipid [3]. In the case of L. pneumophila among over 300 known effector proteins [56, 57] 
many are binding in an Icm/Dot-dependent manner to PI lipids. The Rab1 GEF/AMPylase 
SidM (also known as DrrA) [45, 56, 81, 104, 144], SidCLpn and its paralogous protein 
SdcALpn [80, 103] are binding to PtdIns(4)P, and the retromer interactor RidL [91] is 
known to bind to PtdIns(3)P. In the analogous experiment using L. pneumophila lysate, 
SidM and not SidCLpn was previously found to bind with high affinity to PtdIns(4)P [81, 
145]. It was previously shown that the amino acids 340 to 647 of SidM, which contain the 
GEF domain and the P4M domain, had a higher binding affinity to PtdIns(4)P                          
(KD = 30 nM) [104] than SidCLpn has (KD = 243 nM) [3]. The low binding affinity of 
SidCLpn to PtdIns(4)P could be the reason why SidCLpn was not even detected in the 
absence of SidM [81]. SidCLlo, however, had a KD of 71 nM and thus a 3.4 fold higher 
binding affinity to PtdIns(4)P than SidCLpn as measured by isothermal calorimetry 
measurement (ITC) [3]. Therefore, this assay does not seem to detect binding partners with 
a low affinity to PtdIns or the different PIs. Other L. longbeachae proteins could also form 
complexes with PtdIns or PI binding proteins of L. longbeachae and thus prohibit the 
pulldown. Chaperones like DnaK could be possible interaction partners.  
The P4C domain of SidCLlo was found in an assay using “PIP-strips” to localize to the 
amino acid region 609 to 769 (Figure 3.2B) [3]. This region is analogous to the P4C 
domain of SidCLpn which is localized in the amino acid region 609 to 776 [103]. The 
binding affinity of SidCLlo to PtdIns(4)P was also in this case much higher than the affinity 
of SidCLpn to PtdIns(4)P analyzed with “PIP-arrays” (Figure 3.2C) [3]. This result was 
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supported by the ITC measurement mentioned before [3]. SidCLpn_P4C is binding stronger to 
PtdIns(4)P than SidCLlo_P4C (Figure 3.2C) [3]. It could be that amino acids outside the 
SidCLlo_P4C domain support the binding and are missing in this assay. Unfortunately, due to 
an insolubility of the P4C domains of the proteins at the high concentrations needed for the 
ITC measurements it was not possible to further quantify the binding affinities of the two 
P4C domains. The influences of the N-terminal domains of SidCLlo and SidCLpn on the P4C 
domain of L. pneumophila and L. longbeachae were tested using PIP-strips and -arrays. 
The chimera proteins showed nearly the same binding affinity towards PtdIns(4)P like the 
corresponding P4C domains (Figures 3.2C, D and E). This result can be due to a missing 
effect of the N-terminal part of SidCLlo or SidCLpn on the binding affinity of the P4C 
domains of L. pneumophila or L. longbeachae to PtdIns(4)P or due to a miss folding of the 
protein. Therefore we cannot say, if the N-terminal domain of SidCLlo and SidCLpn has an 
effect on the binding affinity of the P4C domains of SidCLpn and SidCLlo to PtdIns(4)P. 
Certainly the P4C domains of L. longbeachae and L. pneumophila are the major 
PtdIns(4)P binding part of SidCLlo and SidCLpn. It was shown that despite of their different 
binding affinity to PtdIns(4)P, SidCLlo and SidCLpn share similar secondary structure 
compositions [3], whereas the sequence identity of these two proteins is only 40% (Figure 
3.3) [3]. Also the P4C domains of SidCLlo and SidCLpn consist only of 45% of the same 
amino acids (Figure 3.3)[3]. Therefore, the difference in the sequences could be a reason 
for the differences in the binding affinity. An amino acid exchanges in the P4C domain of 
SidCLlo and SidCLpn might play a role in the different binding affinities to PtdIns(4)P. The 
Icm/Dot-dependent translocation of SidCLlo was analyzed using plasmid-encoded CyaA-
SidCLlo transformed into wild-type and a dotA deletion mutant of L. longbeachae and L. 
pneumophila. Unfortunately, the only Icm/Dot-dependent translocation was shown for the 
positive control CyaA-SidCLpn translocated from L. pneumophila wild-type but not from 
the dotA deletion mutant (Figure 3.5A). In a Western blot analysis using specific anti-SidC 
antibodies it was obvious that only L. pneumophila but not L. longbeachae is producing 
CyaA-SidCLpn and CyaA-SidCLlo (Figure 3.5B). No CyaA specific antibody was available. 
Therefore, it was not possible to show whether the CyaA-tag of CyaA-SidCLpn and CyaA-
SidCLlo produced in L. longbeachae was cut off, or if the fusion proteins are produced at 
all. Even a change in the duration of the induction did not change the results seen in the 
Western blot analysis (data not shown). In a further attempt a plasmid with the                           
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L. longbeachae effector protein CetLI1 coupled to CyaA was obtained from the group of 
Gil Segal to test if a translocation of a L. longbeachae effector protein could be shown at 
all. CetLI1 was published to be translocated when overexpressed in L. pneumophila [58]. 
After transformation of the CyaA-CetLI1-producing plasmid into wild-type and a dotA 
deletion mutant of L. longbeachae and L. pneumophila, a cAMP assay was performed. In 
repeated attempts using different lysis methods, the protein CetLI1 was only translocated 
by L. pneumophila wild-type but not by L. longbeachae wild-type (Figure 3.5C). This 
ruled out that the change of the cell line from HL-60-derived human macrophages used 
from the group of Gil Segal [58] to RAW 264.7 macrophages used in this experiment 
could be the reason for the failure to observe translocation in the case of L. longbeachae 
wild-type. Maybe the capsule of L. longbeachae prevents the detection of translocation in 
this assay. In another attempt the new SidCLlo antibody was used in an 
immunofluorescence assay using RAW 264.7 macrophages to verify if SidCLlo is 
translocated in an Icm/Dot-dependent manner. Around 50% of the LCVs harbouring wild-
type L. longbeachae were positive for endogenous SidCLlo whereas the translocation of 
SidCLpn was slightly more efficient. This could be due to the higher amount of SidCLpn 
produced compared to the endogenously produced SidCLlo. Nearly no SidCLlo or SidCLpn 
localization was visible on a LCV harbouring the dotA deletion mutant of L. longbeachae 
(Figure 3.6). Therefore SidCLlo is translocated in an Icm/Dot-dependent manner. 
In the next step the role of SidCLlo in the intracellular replication of L. longbeachae in 
RAW 264.7 macrophages and A. castellanii was characterized more closely. To this end, a 
sidCLlo deletion strain [3] was used. The infection rates were similar for the wild-type and 
the sidCLlo deletion strain, whereas the dotA deletion mutant did not grow (Figure 3.7) [3]. 
The wild-type strain of L. longbeachae outcompeted the sidCLlo deletion strain in a direct 
competition assay within 24 days of A. castellanii infection (Figure 3.8A). Both strains 
grew equally alone in A. castellanii (Figure 3.8C). In the case of a wild-type                                
L. pneumophila strain compared to a sidC-sdcALpn deletion mutant the wild-type won the 
competition within 12 days (Figure 3.8B). Again both strains grew equally alone in                      
A. castellanii (Figure 3.8D) [3]. Therefore, SidCLlo seems to be less important for the 
infection of A. castellanii than SidCLpn and SdcALpn. The reason remains unclear. A similar 
competition defect was previously observed for the Icm/Dot-translocated protein LegG1, a 
Ran GTPase activating effector [84, 146]. 
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We analyzed the effect of SidCLlo in the ER recruitment to the LCV in D. discoideum 
infected with L. longbeachae. The cells rounded up right after the infection and were lost 
during the washing steps of the immunofluorescence labeling. In a direct comparison 
between a wild-type and a dotA deletion mutant of L. longbeachae it was shown that the 
effect was Icm/Dot-dependent (Figure 3.10). A cytotoxic effect of L. longbeachae on                  
D. discoideum could be ruled out (Figure 3.11). The cell surface seems to get modified and 
therefore the cell is not able to attach to the surface any longer. Effector proteins are 
known for L. pneumophila, which modulate the cytoskeleton. For example the Icm/Dot-
dependent L. pneumophila effector protein LegG1 activates the small GTPase Ran and 
promotes the migration of D. discoideum [146, 147]. LegG1 is missing in the genome of  
L. longbeachae [26]. Other Icm/Dot-dependent effector proteins of L. longbeachae could 
interfere with the cytoskeleton. A lack of these effector proteins could result in a cell which 
rounds up. 
Calnexin recruitment to the LCV in infected D. discoideum was impaired due to the loss 
of the L. pneumophila genes sidCLpn and sdcALpn. The decreased calnexin recruitment can 
be complemented by overexpressing SidCLpn or SdcALpn [103]. Calnexin-GFP                        
D. discoideum were infected with a L. pneumophila sidC-sdcALpn deletion strain 
harbouring a plasmid encoding for SidCLlo and the cells were fixed with paraformaldehyde. 
Only few LCVs were covered with calnexin-GFP (Figures 3.12A and B). This result did 
not alter in an infection from one till four hours (Figure 3.12C).  
In a next step, life cell imaging was used to assay the ER recruitment with                            
L. pneumophila infected D. discoideum (Figure 3.13). Using this approach a 
complementation of the loss of the calnexin recruitment to the LCV in cells infected with 
L. pneumophila lacking the sidC-sdcALpn genes with SidCLlo was observed (Figure 3.13) 
[3]. Therefore, the fixation of the cells seemed to affect the calnexin-GFP signal on the 
LCV. Why this influenced only the calnexin-GFP recruitment in the complementation 
assay with SidCLlo remains unclear. Afterward we analyzed the ER recruitment with L. 
longbeachae infected D. discoideum with life cell imaging (Figure 3.14). LCVs harbouring 
wild-type L. longbeachae were calnexin-GFP positive. The dotA and sidCLlo gens were 
necessary for the calnexin recruitment to the LCV infected with L. longbeachae. A 
complementation of the loss of the calnexin recruitment to the LCV was possible through 
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overexpression of SidCLlo, SidCLpn and SdcALpn (Figure 3.14) [3]. Despite of a sequence 
identity of only 40% both SidC effectors proteins seem to be functionally redundant.   
The PHFAPP1 domain binds through PtdIns(4)P to the LCV [80]. Also SidCLlo_P4C and 
SidCLpn_P4C bind to the L. pneumophila-containing vacuole with nearly the same efficiency 
as the PHFAPP1 domain [3]. Therefore, SidCLlo_P4C and SidCLpn_P4C can be used as LCV 
markers (Figure 3.15). 
The results of this study pave the way for further analysis of the role of SidCLlo in the 
ER recruitment to LCVs. Also, the first antibody against a L. longbeachae effector is now 
available to characterize the L. longbeachae-containing vacuole more closely. 
 
4.2 Purification of LCVs from L. longbeachae 
At the onset of this project no antibody was available which recognized any known              
L. longbeachae effector protein covering the LCV. Yet, the translocation of SidCLpn to the                    
L. longbeachae-containing vacuole was observed in infected D. discoideum cells, and 
SidCLpn covered the whole LCV (Figure 3.17). Hence a purification of a L. longbeachae-
containing vacuole was tried using L. longbeachae harbouring a plasmid coding for a 
Dsred protein and SidCLpn (Figure 3.19). LCV purification with L. pneumophila producing 
Dsred was done as a control (Figure 3.18). The previously published protocols were used 
for the LCV purification [2, 54, 140, 141]. Many cells were lost during the washing step 
due to the fact that the D. discoideum cells detached from the flask within minutes after 
adding L. longbeachae. Therefore, a protocol without washing was used in further 
experiments (Figure 3.19). An enrichment of the LCVs in the eluate was visible and the 
amount of LCVs was comparable to the amount of LCVs obtained in the control 
experiment with L. pneumophila wild-type. A Histodenz gradient was used to get rid of 
extracellular bacteria and cell debris. Unfortunately, the amount of LCVs decreased 
significantly and much cell debris remained. Nevertheless most of the LCVs were found in 
fraction 4 (Figure 3.19). The amount and purity of the LCVs was not enough for a 
proteome analysis of L. longbeachae-containing vacuoles. The purification step with the 
Histodenz gradient seems not to be optimal for the purification of L. longbeachae-
containing vacuoles. An alternative purification step should be tried. Therefore, other 
gradients like “OptiPrepTM Density Gradient Medium” (Sigma) could be tried. 
4. Discussions 
 
80 
 
A purification of L. longbeachae-containing vacuoles from infected RAW 264.7 
macrophages was tried. Again a purification of L. pneumophila-containing vacuoles was 
performed as a positive control (Figure 3.20). After infection of the RAW 264.7 
macrophages with L. longbeachae harbouring a plasmid coding for Dsred and SidCLpn the 
cells did not detach from the flask like D. discoideum. Few LCVs were found in the eluate 
and in fraction 4. A separation of the LCVs from extracellular bacteria and cell debris was 
obtained but the number of LCVs visible in fraction 4 was much too low for a proteomic 
analysis (Figure 3.21).  
During this work a SidCLlo antibody was raised. Therefore, a purification of                          
L. longbeachae-containing vacuoles from RAW 264.7 macrophages using endogenous 
SidCLlo and the corresponding antibody was tried. Unfortunately, the yield of LCVs was 
from the beginning much lower than in the experiments with overexpressed SidCLpn 
(Figures 3.20 and 3.22). The few LCVs were lost during the enrichment process in the cell 
suspension and upon running the sample through the MACS column. Therefore, only 
extracellular bacteria were found in fraction 3 and 4 (Figure 3.22). We have noticed that 
the sample took much longer to rinse through the column than the L. pneumophila samples. 
Maybe the column was clogged and the LCVs were retained by the column. The reason for 
this remains unclear. 
In all preparations SidCLpn or SidCLlo rarely cover the LCV completely. If SidCLpn was 
overexpressed the amount of SidCLpn translocated to the LCV membrane was much higher 
than the amount of SidCLlo which is produced endogenously. Therefore, recognition of 
LCVs in the samples and binding of the LCVs to the MACS column was enhanced. As a 
consequence, the purification of L. longbeachae-containing vacuoles from RAW 264.7 
macrophages could be more efficient with a strain overexpressing SidCLpn than with the 
endogenous produced SidCLlo (Figures 3.20 till 3.22). Also an increased cell number could 
be tried. However, further cellular analysis of the influence of SidCLpn on the protein 
composition of L. longbeachae-containing vacuoles need to be done, if a L. longbeachae 
strain harbouring Dsred and SidCLpn is used to obtain LCVs for a proteomic analysis. 
Alternatively, other L. longbeachae effector proteins which cover the LCV completely and 
an antibody against this protein could be used. Thus, the amount of purified LCVs 
harbouring L. longbeachae might be increased.  
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5. General conclusions and outlook 
In my Ph.D. thesis I have analyzed the first Icm/Dot-dependent effector protein of                       
L. longbeachae, SidCLlo. SidCLlo binds with a distinct P4C domain to PtdIns(4)P located on 
the LCV. This P4C domain can be used as a LCV marker in immunofluorescence assays. 
The binding affinity of SidCLlo to PtdIns(4)P is much higher compared to SidCLpn. Just as 
SidCLpn SidCLlo is also important for ER recruitment to the LCV, and therefore, plays a 
pivotal role in the pathogen-host interaction. Interestingly, this effect could be 
complemented by adding plasmid-encoded SidCLlo or SidCLpn in reciprocal assays. Both 
proteins seem to improve the intracellular replication of L. longbeachae and                       
L. pneumophila in infected A. castellanii. Despite of a small sequence identity and the 
difference in the binding affinities to PtdIns(4)P both proteins seem to play similar roles in 
the intracellular replication of L. longbeachae. 
 
 
 
Figure 4.1. The Icm/Dot-dependent effector protein SidCLlo is binding through PtdIns(4)P to                                
L. longbeachae-containing vacuoles and interacts with the ER. SidCLlo is translocated by the Icm/Dot 
T4SS into the host cell cytoplasm and binds through PtdIns(4)P to the L. longbeachae-containing vacuole. 
The effector protein SidCLlo interacts with the ER [3]. SidM and SdcA are missing in the genome of L. 
longbeachae [26]. 
 
We started to isolate L. longbeachae-containing vacuoles from D. discoideum or RAW 
264.7 macrophages with protocols previously published [2, 54, 140, 141]. To this end, we 
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overexpressed SidCLpn in L. longbeachae and used an anti-SidCLpn antibody for the 
purification. The isolation from LCVs from D. discoideum worked much better than the 
isolation from RAW 264.7 macrophages. We raised the first known antibody against a           
L. longbeachae effector protein, which recognizes only SidCLlo but not SidCLpn. This 
antibody was used to isolate L. longbeachae-containing vacuoles from infected RAW 
264.7 macrophages. Unfortunately, this attempt failed. Further investigations need to be 
done to optimize the existing protocols for a purification of L. longbeachae-containing 
vacuoles. Thus, it should be possible to isolate L. longbeachae-containing vacuoles at least 
from infected D. discoideum in an appropriate yield and purity to analyse their proteome. 
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6. List of abbreviations 
Amp  ampicillin 
AMPylation adenosine mono-phosphorylation 
APS ammonium persulphate 
ARF ADP ribosylation factor 
AYE  ACES yeast extract 
BSA bovine serum albumin  
Caln calnexin 
Cam  chloramphenicol 
CetLI C-terminal signal for effector translocation of L. longbeachae 
cfu  colony forming units 
CYE  charcoal yeast extract 
DAG diacylglycerol  
Dd5P4  Dictyostelium discoideum 5-phosphatase 4 
DFA direct fluorescent antibody 
dot  defective in organelle trafficking 
EDTA ethylendiamintetraacetate 
EEA1 early endosomal antigen 1  
EGTA ethylenglycol-bis(aminoethylether)-N, N, N’, N’-tetra acetic acid  
ER  endoplasmic reticulum 
FAPP1 phosphatidylinositol (4) phosphate adaptor protein 1 
G418 geneticin sulphate 
GAP GTPase-activating protein 
GDI guanine nucleotide dissociation inhibitor 
GDF GDI displacement factor 
GEF guanine nucleotide exchange factor 
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icm  intracellular multiplication 
IPTG  isopropyl-ß-D-thiogalactopyranoside 
ITC isothermal titration calorimetry 
Kan  kanamycin 
KD dissociation equilibrium constant 
kDa kilo Dalton 
LAMP1  lysosomal associated membran glycoprotein 1 
LB Luria-Bertani 
LCMS liquid chromatography-mass spectrometry 
LCV  Legionella-containing vacuole 
LidA lowered viability in the presence of dotA 
LPA lysophosphatidic acid 
LPC  lysophosphocholine 
MALDI-TOF matrix-assisted laser desorption/ionization-time of flight 
MOI  multiplicity of infection 
MOPS 3-(N-morpholino)propane sulfonic acid 
MVB multivesicular bodies 
OCRL1  oculocerebrorenal syndrome of Lowe 1  
OD600  optical density at 600nm 
P4C PtdIns(4)P-binding of SidC 
P4M PtdIns(4)P-binding of SidM/DrrA 
PA phosphatidic acid 
PBS  phosphate-buffered saline 
PC phosphatidylcholine 
PE phosphatidylethanolamine 
PFA  paraformaldehyde 
PH pleckstrin homology 
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PI  phosphoinositide 
PI3K phosphatidylinositol 3-kinase 
PI4KIIIß PtdIns 4-kinase IIIß  
PMSF phenylmethylsulfonylfluoride 
PS phosphatidylserine 
psi pound-force per square inch 
PtdIns  phosphatidylinositol 
PtdIns(4)P phosphatidylinositol(4)phosphate 
RalF recruitment of Arf to Legionella phagosome 
rER rough endoplasmic reticulum 
RT room temperature 
S1P sphingosine-1-phosphate 
SDS sodium dodecyl sulfate  
Sg1 serogroup 1 
SidC substrate of Icm/Dot transporter 
SorC Sörensen phosphate buffer 
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